University of Memphis

University of Memphis Digital Commons
Electronic Theses and Dissertations
4-19-2017

Essays in Applied Microeconomics
Toluwalope Adekunle Ayangbayi

Follow this and additional works at: https://digitalcommons.memphis.edu/etd

Recommended Citation
Ayangbayi, Toluwalope Adekunle, "Essays in Applied Microeconomics" (2017). Electronic Theses and
Dissertations. 1635.
https://digitalcommons.memphis.edu/etd/1635

This Dissertation is brought to you for free and open access by University of Memphis Digital Commons. It has
been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of University of
Memphis Digital Commons. For more information, please contact khggerty@memphis.edu.

ESSAYS IN APPLIED MICROECONOMICS
by
Toluwalope Adekunle Ayangbayi

A Dissertation
Submitted in Partial Fulfilment of the
Requirement for the Degree of
Doctor of Philosophy

Major: Business Administration

The University of Memphis
May 2017

Copyright © Toluwalope Adekunle Ayangbayi
All rights reserved

ii

DEDICATION
To God, who made me, and without whose help this work would not have been possible.
To my family, for all your support and perseverance.

iii

ACKNOWLEDGEMENTS
I am immensely grateful to the Chair of my dissertation committee, Dr. Albert A.
Okunade for mentoring and guiding me through the completion of the Ph.D. program. The
energy, passion, and enthusiasm to see his students excel, and his unflinching optimism about
the future is always a source of motivation. I am indeed appreciative.
The support and advice of the members of my dissertation committee, including Dr.
Cyril Chang, Dr. Andrew Hussey and Dr. E. Olusegun George, during the completion of this
dissertation are appreciated. Comments and suggestions of participants at sessions of the
meetings of the Midwest Economics Association, International Health Economics
Association and the American Society of Health Economists, where initial drafts of the
essays in this dissertation were presented are also acknowledged.
My gratitude also goes to the faculty, staff, and students in the Department of
Economics, the Fogelman College of Business & Economics, and across the University of
Memphis for making my time in graduate school academically rewarding, interesting and
memorable. In particular, I want to thank Dr. William T. Smith (Chair, Economics
Department), for providing funds to purchase data analyzed in part of this dissertation and for
sponsoring my participation in academic conferences where my papers have been presented,
and Ms. Janis Lamar, for ensuring a smooth ride on the administrative side.
I also acknowledge the support of and encouragement of my friends especially Dr.
Thierry Nianogo who facilitated a ‘soft landing’ in Memphis.
Finally, I am grateful to my parents, siblings, cousins, in-laws and everyone in my
extended family who helped to cushion the shocks created by my return to graduate school.
Iyobosa, Olujimi and Oluwatoni, returning home to your smiles at the end of each day gave
me the strength to continue.

iv

ABSTRACT
Ayangbayi, Toluwalope Adekunle. PhD. The University of Memphis. May 2017.
Essays in Applied Microeconomics. Major Professor: Dr. Albert A. Okunade.
My dissertation comprises three essays in which I apply methods based in economics
to policy-relevant questions in health care economics. The essays in the successive chapters
study the determinants of prescription drug utilization using U.S. county level data;
relationship between household health and socioeconomic factors; and impact of treatment
adherence on health capital stock in Chronic Obstructive Pulmonary Disease in the US. The
first essay uses county level data to study the impact of habit formation in an econometric
study of determinants of US prescription drug utilization. Results suggest that habit formation
is the most important driver of current prescription use. The second essay is an econometric
study of the socioeconomic determinants of child health in Nigeria using household level data
partitioned into rich and poor wealth groups. I find positive and statistically significant effects
of maternal education on child health in the short and long runs in rich and poor groups of
households. The third essay studies the relationship between treatment adherence (smoking
cessation and annual influenza vaccination) and health stock in COPD by analyzing data of
individuals with Chronic Obstructive Pulmonary Disease (COPD) in the US. I model the
decision to invest in personal care as a two-stage process using the double hurdle model.
Results suggest that relative to non-adherence, full adherence increases the probability of an
effect on the health stock and conditional on having an effect, increases the capital stock of
health.
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CHAPTER 1
INTRODUCTION
Health and healthcare issues continue to generate significant interest among policy
makers and academics all over the world especially because of the implications of health for
productivity and economic growth. An aging population and scarce resources for healthcare
further reinforces the need for evidence based resource allocation and policy-making for
health care. Therefore, using methods and theories based in economics, this dissertation
contributes to the body of knowledge that informs healthcare decisions. The dissertation
comprises three essays that employ methods based in economics to answer policy-relevant
questions in health and health care issues in the U.S. and Nigeria. The essays in the
successive chapters study the determinants of prescription drug utilization using U.S. county
level data; the relationship between household health and socioeconomic factors in Nigeria;
and the impact of treatment adherence on health capital stock in Chronic Obstructive
Pulmonary Disease in the US.
In the first essay, the determinants of prescription drug utilization in U.S. is
econometrically modelled using county level data in the states of Arkansas, Idaho, North
Dakota, South Dakota, Tennessee, Washington and West Virginia. Prescriptions are studied
due to the implication of higher prescription drug spending for the growth of the high U.S.
healthcare expenditures. Greater demand for expensive specialty drugs, fewer expiring
patents and rising per capita prescriptions filled emanating from expanded insurance
coverage access are responsible for increased use of prescriptions in the U.S. Consequently,
this timely study uses recent data on US counties and a flexible Box-Cox transformation
model to probe the correlates of prescription drug utilization. Second, I test statistical
hypothesis on the rarely entertained role of inertia (e.g., from treating chronic diseases) as a
determinant of current period’s prescription drug use. Third, I fitted separate regression
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models to the data partitioned into low and high utilization counties to account for possible
heterogeneity. The regression estimates suggest that: the optimal functional form model
depends on utilization intensity; habit formation (inertia) is the most important driver of
current use; and primary care physician density, lagged income and education effects are
significant. Consistent with some past findings and the negative correlation observed between
income and prescription drug use, the Box-Cox income elasticities of -0.35 and -2.25 in lowand high- utilization groups of counties suggest that US prescription drug utilization (90
percent generics) behaves like an inferior commodity. Consequently, demand-side
management policies should consider differences in utilization intensities.
In the second essay, I estimate the relationship between household socioeconomic
status and child health in Nigeria. Most of the available studies in this area have largely been
conducted on the developed world with disproportionately fewer studies on developing
countries including especially, African. Specifically, there are currently few econometric
studies on health status inequalities across socioeconomic bands focusing on Nigeria. This
investigation, using the latest available pooled data from three waves (1999-2003, 2004-2008,
and 2009-2013) of the National Demographic and Health Surveys in Nigeria, estimates
econometric models of the socioeconomic gradient in health. Departing from the norm in
most of the published studies that used subjective self-reported health status, I use objective
measures of child health status used for growth monitoring in children, e.g., height-for-age
(HAZ), weight-for-height (WHZ), and weight-for-age (WAZ). Using these metrics reduces
endogeneity due to measurement error in the dependent variable. The use of child health to
proxy household health status further reduces endogeneity of wealth or income in a health
production model. A third strategy for reducing endogeneity is implicit in using wealth index
factor scores data partitioned into wealth groups (above (richer) and below (poorer) the
median wealth factor score for each survey) and then estimating separate models for each
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wealth band. Results based on ordinary least squares estimation method reveal positive and
statistically significant effects of maternal education in all models except for the poorer group
of the WHZ model. Surprisingly, paternal education has no significant effect on any of the
measures of health status. Third, depending on the model and wealth group, child (e.g.,
gender, age, birth-weight and birth interval) and environmental (e.g., rural residence,
geopolitical zone of residence and household size) factors play important roles in health
production. Fourth, variations exist across the core correlates of health depending on the
measure. Finally, these findings could inform future policy interventions (e.g. under the
sustainable development goals) targeting improved health status of Nigerians.
In the final essay, I model the decision to adhere to treatment in Chronic Obstructive
Pulmonary Disease (COPD), the third leading cause of mortality and morbidity in the U.S.
The disease also exerts a significant economic burden on the healthcare system. Efficacious
treatment strategies include slowing down disease progression, relieving symptoms, and
increasing exercise tolerance. Effectiveness of smoking cessation and annual influenza
vaccination depend upon a patient’s adherence. The study tests the hypothesis that adherence
affects the health stock in COPD patients and adds to the treatment adherence literature in
three major ways. First, it extends the research beyond the effects of access to treatment by
focusing on the impact of treatment as well as a patient’s adherence to recommended
treatment. Second, I model adherence to treatment as a two-stage decision process by fitting a
double-hurdle (DH) regression model. Third, nationally representative data are analyzed to
make the findings broadly applicable. Full adherence (smoking cessation and influenza
vaccination) increases the probability of an effect by 4.0 percent and adds 0.67 days of good
health to the capital stock. Quitting smoking alone increases the probability of an effect by
3.0 percent and adds 0.50 days of good health relative to current smokers. The findings
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support evidence that both strategies are complements and suggest a greater need for patient
education that emphasizes the importance of treatment adherence.
In summary, the goal of my essays is to employ econometric methods to answer
healthcare policy questions with a view to gaining new insights that may be leveraged for
improving health and health care services.
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CHAPTER 2
DETERMINANTS OF PRESCRIPTION DRUG UTILIZATION USING
DATA OF THE US COUNTIES: TESTING FUNCTIONAL FORM
MODELS WITH HABIT FORMATION
Introduction
Prescription drugs are the third largest and a rising component of US healthcare expenditures.
Understanding the correlates of prescription drug use is crucial when designing better policies
for managing demand growth and containing rising costs. US prescription drug utilization is
the highest and it exceeds the median among the Organization for Economic Cooperation and
Development (OECD) countries (Squires, 2011). The resurgent rise in US healthcare
spending (Martin, Hartman, Benson et al., 2016) is attributed to the rise in prescription drug
spending, stealthy rise in the demand for costly specialty drugs, fewer expiring patents of
blockbuster drugs and rising volumes of prescriptions filled at retail arising from insurance
coverage expansion under the 2010 Affordable Care Act. Nearly three-quarters of the 11
percent rise (3.54 billion in 2010 to 3.92 billion in 2014) in the number of prescriptions filled
arose from growth of per capita prescriptions (US Department of Health and Human
Services, 2016).
Therefore, studying the determinants of US prescription drug use is timely and relevant
(Schumock et al., 2014) for many reasons. Foremost, greater usage of prescribed medicines is
one of the core drivers of drug spending in the next decade (Keehan et al., 2015). With a
growth of 12.5 percent over the previous year in 20141 and projected growth compounded at
6 percent annually from 2014 to 2024, prescriptions are broadly used diagnostic, curative,
and health maintenance technology (ibid). The IMS Institute for Healthcare Informatics
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The Novartis Pharmacy Benefit Report estimated 15.9 percent growth in retail pharmaceutical spending from
2013 to 2014 with 1.7 percent growth in the volume of retail prescriptions during the same period (Novartis,
2015). In the US, 72 percent of all drug expenditures are retail (US Health and Human Services, 2016).
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(IMS, 2015) also projected greater prescription drug use due to broadened access to new
(e.g., retail clinic visits) and traditional providers attributable to ongoing implementation of
the 2010 US healthcare reform (Martin, Hartman, Benson, et al., 2016).
Past studies (see, Appendix Table 1) mostly used prescription expenditure as proxy for
utilization, but this may be inaccurate for the US where utilization and price often depend on
the type and generosity of insurance plans. Also, since drug expenditures may be sensitive to
price growth, high expenditures may not fully reflect quantities used (Berndt, 2002). Finally,
recent stealthy rise in expenditures on high cost specialty2 and generic drugs suggests that
expenditure would be a noisy proxy for utilization (Alpern et al., 2014). The study departs
from past practice by measuring utilization as the annual per capita number of prescriptions
filled.
Greater use of generics largely drove prescription drug expenditures during 2011 and
2012 (Healthcare Cost Institute, 2013 and 2014). Studies of prescription drug utilization are
sparse, however. Nianogo et al. (2015), using 2011 cross-sectional county level data of seven
US states, measured utilization as the number of prescriptions filled at retail. This measure
isolates quantity of drugs consumed from the price effect. They estimated a classic Box-Cox
regression model but omitted the theoretical importance and practical relevance of inertia or
habit formation on current use of prescriptions. Standard models of prescription drug
utilization (and expenditure) may be misspecified due to simultaneity of education, health
status, and income (Leth-Petersen and Skipper, 2014) or bias from not capturing the habitual
nature of the demand for prescribed medicines (Okunade and Suraratdecha, 2006).
The unique contributions of the study are many. First, for the first time in the
literature, we test the importance of inertia (‘past use’ or ‘habits’) as a determinant of current

2

Spending on treatments for Hepatitis C in 2014 was about $11.6billion, a 14,051 percent rise over the previous
year (Novartis, 2015). Hartung, Bourdette and Ahmed et al., (2015) also observed an increase in the cost of
drugs for multiple sclerosis from $8-11,000 per year to about $60,000 per year. See also Schondelmeyer and
Purvis, 2015.
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period’s number of filled prescriptions (not expenditure). Second, we fit the classic Box-Cox
(power-transformed dependent variable) model to the more recent (2011 and 2012) data,
which includes as determinants the utilization inertia, lagged household income, share of
adults with post-secondary education, and other socio-demographic and economic controls.
Finally, we partitioned the dataset into two groups – above average (or ‘high-use’) and below
average (or ‘low-use’), to account for different utilization intensities and elicit plausible
changes in the economic nature of prescriptions as a good.3
The empirical econometric results indicate that the optimal functional form model
varies with utilization intensity (low versus high). Lagged (year 2011) prescription utilization
is positively and significantly associated with current (year 2012) utilization for the different
utilization intensities. Primary care (‘gate-keeping’) physician density effect is positive in
both high and low utilization groups but the magnitude is greater and significant in the low
intensity of use model. The estimated income elasticities of utilization (not expenditures) are
-2.25 (high-use counties) and -0.35 (low-use counties); they suggest that prescription drugs,
comprising 90 percent generics in the US (Chin, 2015), behave as an inferior good. These
results suggest that utilization management policies consider differences in usage intensities
and the economic nature of prescription drugs as utilizations change.
Section II focuses on the empirical model strategy. Section III discusses the data,
Section IV presents the results for discussion in Section V, and Section VI concludes.

3

Our study differs materially, in at least three ways, from that of Nianogo et al., (2015), as follows. (1) We test
and find relevance for the habit formation thesis, a consideration they missed. (2) While they partitioned their
2011 cross-sectional data into 3 user groups (high, medium and low) the low user group comprising counties in
only 1 U.S. state limits the richness of their findings for that group. (3) Our study is based on data 2011 and
2012 data partitioned into 2 user groups: above (high users) and below (low users) the mean, as this grouping is
more relevant to policymakers who are naturally interested in the position relative to the ‘average.’ The Office
of Inspector General, e.g., monitors fraudulent Medicare Part D prescribing by comparing prescriptions at each
pharmacy with the US average (see, http://oig.hhs.gov/oei/reports/oei-02-15-00190.pdf).
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Empirical Strategy
The model borrows from that of Grossman’s (1972) demand for health as a durable capital.
Demand for health lies behind utilization of healthcare resources, prescription drugs included.
More generally, health production entails the use of prescription drugs, medical care services,
time, lifestyle factors (e.g., exercise, smoking cessation), education and other factors. Health
production involving use of prescription drugs may occur as a short episode of treatment of
an acute health shock or more frequently for the treatment of a chronic health conditions.
Habitual medication use may occur with prescription and non-prescription drugs and in drug
dependence or addiction. The consequences of habitual prescription use are prevalent in
clinical medicine literature; e.g., see Perneger, Whelton and Klag (1994) on habitual use of
acetaminophen, aspirin, and non-steroidal anti-inflammatory drugs, and Roerig et al. (2010)
on laxatives.
Habit formation is an observable characteristic of consumer behaviour when
consumers delay or partially adjust demand following a change in income or relative prices of
commodities or when past consumption determines current consumption (Okunade, 1992).
One implication is that adjustment towards the new equilibrium occurs over multiple periods
(Phlips, 1974). Loewenstein, Price, and Volpp (2016) study the effect of incentives on
engaging in a healthy behaviour and conclude that short-term incentives could lead to habit
formation; and longer-term incentives could lead to longer-term effects. Habit formation in
prescription use can originate from the supply or demand side. On the supply-side, physician
practice style due to uncertainty around diagnosis and treatment (Eddy, 1984) may lead to
over-prescribing and thus promote habitual drug use. Larochelle et al. (2016), using a
commercial insurance claims database, reports that most patients experiencing non-fatal
opioid overdose continued using the prescribed drugs following recovery. Physicians
continue prescribing opioid drugs following non-fatal overdose due to: inadequate monitoring
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and information sharing systems, asymmetric information, habitual prescription of opioids as
a preferred alternative to illicit opioid use, and prescribing habits (Gregg (2016).
On the demand side, habit formation may occur after diagnosis of a chronic condition
(e.g., lifelong prescribing of high blood pressure or diabetes medications). Frequent use of
medications may also occur following the use of potentially addictive prescription drugs
(e.g., morphine for pain or the benzodiazepines for anxiety). Therefore, current prescription
drug use relates to that of the previous period (i.e., consumption at time t is a function of
consumption prior to and up to time t-1 and consumption at time t-1 is a function of
consumption prior to and up to time, t-2 etc.) Consumption at time t may also be due to
prescription drug adherence in past periods. For example, poor adherence to treatment for an
acute condition (such as, inappropriate use of antibiotics leads to worldwide antibiotic
resistance and may necessitate prescribing of different antibiotics due to persistence of
infection.)4 Given the established relationship between current and past period prescription
use, a one period lagged consumption effectively captures accumulated habits (Okunade,
1992; Leth-Petersen and Skipper, 2014).
The following is the specification of the prescription utilization model, in which the
number of annual prescriptions filled (PF) at retail pharmacies at the county level depends on
population health and behavioural factors, demographics, access to care, and socioeconomic
factors:
PF = f (health factors, access factors, socioeconomic status, demographic factors)

(2.1)

Unlike Nianogo et al. (2015) and Di Matteo (2005) the current model includes one period
lags of prescription drug utilization, education and income, where the lagged prescription
captures inertia or habit formation. Lags in the model mitigate endogeneity due to reverse

4

This is analogous to a situation in which there is inefficient production of health resulting in the use of more
than the optimal factor inputs for health production.
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causality as current period prescription utilization does not determine previous period
utilization.
Utilization (e.g., prescription drugs) and expenditure data have skewed distributions
due to long-term users having greater than average consumption (Berndt, 2002). Skewness of
the dependent variable in the model thus, precludes Ordinary Least Squares (OLS) regression
estimation. Grootendorst (1995) discusses limitations of the OLS relative to the more suitable
alternative models. I implemented Maximum Likelihood (ML) estimation of the classic
Box-Cox (CBC) regression model. The variance stabilizing CBC model suitably
transforms skewed data to normality (Box and Cox, 1964; Yang and Tse, 2006) and it nests
linear, inverse and log functional forms as special cases. The model estimation involves
numerical optimization for computing the optimal transformation parameter (that is, λ.) of the
dependent variable. The general form of the CBC model is
𝑌 (λ) = 𝑋𝛽 + 𝜖

(2.2)

Where, 𝑌 (λ) , X, β and 𝜖 are, respectively the transformed dependent variable, untransformed
independent variables, the regression slopes, and the independently and identically distributed random
errors. Equation (2.2) in the context of the regression model for this study, therefore takes
the form:
𝑃𝐹𝑖𝑡 (λ) = 𝛼 + 𝛽𝑀𝑖𝑡−𝑙 + η𝐸𝑖𝑡−𝑙 + τ𝐼𝑖𝑡−𝑙 + ∑𝐽𝑗=1 𝛾 𝑿𝒊𝒋𝒕 + 𝜖𝑖𝑡
𝑗

λ
𝑃𝐹𝑖𝑡
−1

where,

𝑃𝐹𝑖𝑡 (λ) = {

λ

,

𝑖𝑓 λ ≠ 0

(2.3)

(2.4)

Ln(𝑃𝐹𝑖𝑡 ) , 𝑖𝑓 λ = 0
In the equations above, PFit is annual per capita number of prescriptions filled at retail in
county 𝑖 at time t, Mit-l is the log of one-period lagged PFit cumulative up to period l (where
lag length l=1), Eit-l is lagged proportion of population with post-secondary education, and Iit-l
is log of lagged median household income in a county. Moreover, Xijt is a vector of control
variables j including healthcare access, socioeconomic and demographic factors and state
10

dummies and α, β, η, τ and γ are the model parameters with γ, the coefficient vector of the
other correlates; and 𝜖𝑖𝑡 the independent and normally distributed random residuals with
constant variance and zero mean. Finally, the optimal λ power transformation parameter for
the CBC5 response variable and the regression parameters are jointly estimated using ML
method. I evaluate the estimated Box-Cox model elasticities6 at the sample data means.
Finally, the likelihood ratio (χ2 distribution) test is, respectively used for hypotheses tests on
the Box-Cox λ (Whistler et al., 2011) and on the difference between models with
(unrestricted) and without (restricted) habit formation.
Data and Definition of Variables
Data analysed came from the total annual county level number of prescriptions filled during
2011 and 2012 in seven randomly sampled US states, purchased from a private source,
SK&A, an IMS company, and University of Wisconsin Population Health Institute’s County
Level Rankings. SK&A’s National Pharmacy Market Report database contains the annual
number of prescriptions filled and the number of retail community pharmacies in each
county obtained from a survey of 4,753 pharmacies in Arkansas, Idaho, N. Dakota, S.
Dakota, Tennessee, Washington and W. Virginia. Data on prescription orders by type or
class of drug and drug prices are unavailable to the public, however. The County Level
Rankings database provides county-specific health, socio-economic and demographic data.
Table 1 presents descriptive statistics of the data and the definition of variables.
Among the 427 counties, 173 had annual per capita number of scripts filled greater than the
sample mean (high-use), and 254 counties filled less than the sample mean (low-use). The

5

We experimented separate fully flexible bivariate regressions of count of prescriptions filled per capita on the
lagged count of prescriptions filled and real median household income. Transformation λ in each was
approximately zero for both sides suggesting a double log transformation and so we included the natural log forms
of these two variables in the CBC estimation.
6

For instance, the Box-Cox elasticity of utilization with respect to income at the mean value of income is estimated
̅̅̅̅̅
𝑖𝑛𝑐
as: 𝛽𝑖𝑛𝑐 𝑥 (̅̅̅̅λ ), where 𝛽𝑖𝑛𝑐 is the coefficient on income and ̅̅̅̅
𝑃𝐹 𝜆 is the mean value of the predicted count of
𝑃𝐹
prescriptions at the CBC λ.
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2012 annual per capita number of filled scripts is 2.48 in the high-use group and 1.21 in the
low-use group. Similarly, for year 2011 the mean of (one-period lagged) prescriptions filled
is higher in the high-use group. Not surprisingly, median household income is greater in the
low-use group. Unpaired t-test results (see, Table 1) indicating the two utilization intensity
groups are significantly different justify fitting separate regression models to high- and lowprescription drug utilization groups of counties.
Health and Behavioural Factors
Health stock is another determinant of prescription drug utilization (a healthcare input) with a
higher level of health capital stock reducing need for prescriptions. The relationship can also
run in the opposite direction with prescription drug use acting as an investment in health
capital. In general, prescription drug utilization derives from the demand for better health
since the drugs represent a cost-effective treatment technology for health restoration and or
maintenance. Moreover, in Grossman’s (1972) demand for health model current health stock
depends on previous period’s health stock (less depreciation) and new investment. Thus, a
one-period lagged number of prescriptions filled is an argument in the model to reflect this
relationship with the expectation of a positive correlation of lagged and current drug use.
Prescriptions filled would tend to be associated with the relative preponderance of
population health and behavioural lifestyle factors (Cawley, 2015), as these are inputs in
health production. Lifestyle factors including exercise and healthy nutrition augment health
stock, and smoking and poor dietary habits deplete the stock. Similar to Cuckler et al.,
(2011), the current model incorporates the variable Bad Health Index (BHI), defined as the
multiplication of the rates of obesity and smoking. BHI, an objective measure of
population health status, theoretically correlates positively with prescription drug
utilization. The share of population reporting fair or poor health status, a subjective
measure of health, is also included as a control for population health status.
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Table 1. Descriptive statistics of counties
Factors

Health/Behavior

Variables

Pooleda

Prescriptions per
capita
Prescription per
capitat-1
Bad health index
Fair or Poor Health
PCP Density
Health Access

Pharmacies/100k
Percent uninsured

SocioEconomics

% with postsecondary educationtReal median
household incomet-1
% 65yr and above

% Hispanic
% Female
% Rural

Number of US counties
a
b

High
usersa
2.476
(2.795)
2.02
(0.759)
7.008
(2.684)
17.315
(5.94)
71.679
(53.333)
14.896
(22.853)
17.411
(3.668)
52.881
(13.659)

Mean
differenceb
-1.445***
(-5.49)
-0.922***
(12.62)
-0.055
(-0.19)
0.573
(0.94)
-23.16***
(-4.71)
-5.61**
(2.06)
1.24***
(3.41)
-4.07***
(-3.08)

42661.5
(8522.1)
16.585
(4.561)
5.129
(10.59)
4.365
(6.942)
50.238
(1.608)
69.444
(28.839)
427

42615.5
(8418)
16.452
(4.385)
4.874
(10.322)
5.109
(7.893)
50.026
(1.762)
72.598
(28.91)
254

42427.5
(8696.8)
16.78
(4.815)
5.503
(10.992)
3.272
(5.07)
50.55
(1.293)
64.812
(30.41)
173

-112.53
(0.13)
-0.33
(-0.72)
0.63
(-0.59)
1.84***
(2.93)
-0.53***
(-3.55)
7.79***
(2.71)

1

% Black
Demographics

1.725
(1.902)
1.539
(0.708)
6.98
(2.537)
17.637
(5.846)
59.245
(41.466)
11.97
(25.373)
18.147
(3.738)
50.436
(13.424)

Low
usersa
1.214
(0.36)
1.211
(0.433)
6.96
(2.437)
17.857
(5.782)
50.777
(27.995)
9.976
(26.817)
18.649
(3.709)
48.816
(13.032)

Standard deviation in parenthesis
t-ratio in parenthesis

Health Access Factors
The literature suggests that the number of filled scripts should rise with the share of insured
population, community pharmacy density, gate-keeping primary care physician density,
and other healthcare access points. Retail pharmacy density could correlate negatively
with the number of filled scripts because US doctors are the primary gate-keeping drug
prescribers. The roles of community pharmacies in healthcare provision are poised to
expand due to their evolving roles that increasingly include clinical services (Vecchione,
2016). Sloan and Hsieh (2012) argues that greater geographical access to healthcare
13

resources reduces travel and waiting time costs. These reduce the price of care and raise
utilization of pharmaceutical services.
Moreover, reduction of financial barriers through uptake of health insurance or
prescription benefits that reduce the net price of prescription drugs can further stimulate
demand. This incentivises medication use for the previously uninsured individuals who
gain coverage or if those already covered for prescription benefits use more prescriptions
secondary to lower out-of-pocket payments. Greater use of prescription medicines may
also arise from higher frequency of prescription orders by the physicians, especially due
to third party payers. Asymmetric information7 in the physician-patient relationship may
also incentivise the supply of medically unnecessary scripts. Although US physicians do
not profit directly from writing scripts, incentives for writing unnecessary prescription
orders could arise from the need to maintain patient loyalty and increase physician
income.
Demographic Factors
Demographic factors included in this analysis are the share of adults 65 years and older, share
of females in the population and proportions of the different ethnic groups. Higher prevalence
of failing health among the elderly makes them more likely to consume more healthcare
resources than the younger age groups. Failing health represents increasing health capital
depreciation that necessitates greater investments for restoration and/or maintenance. The use
of maintenance prescriptions could lead to habit formation in utilization in older adults.
Kantor et al., (2015), in analysis of NHANES data, reports that from 1999 - 2012, about 90
percent of US adults above age 65 years, compared with 65 percent aged 40 – 64 years, daily

7

Moreover, due to asymmetric information, a physician may unintentionally overprescribe an unnecessary drug
e.g., an opioid analgesic that a patient reports as being effective (see Gregg, 2016).
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used at least one prescription drug. They also report higher prevalence of polypharmacy
among the elderly.
Kaufman et al. (2002) finds that elderly women use more medications compared with
other groups in the US population. The impact of reproduction on women’s health and longer
life expectancy may contribute to greater use of healthcare resources including prescription
drugs. It is, therefore expected that ceteris paribus, the female population proportion will
correlate positively with medication use. Paulose-Ram et al. (2007), using NHANES III and
NHANES 1999-2002 data of the US population, reports greater use of psychotropic drugs in
US women than men and higher use among Caucasians than African-Americans and
Mexican-Americans. This study includes the shares of African-Americans and Hispanics
(relative to Caucasians) as controls to capture ethnic population disparities in prescription
drugs use.
Socioeconomic Factors
The literature confirms social gradient in health; that is, the observation that individuals
in the upper socioeconomic strata usually report better health than those in the lower
strata leads us to expect individuals with higher incomes to use fewer prescriptions.
Stagnitti (2009), in analyses of Medical Expenditure Panel Survey (MEPS) 2006, finds
prescription drug use to increase with poverty.
The relationship between income and healthcare demand is not as straightforward,
however. Several studies (see Appendix Table 1) reporting income elasticities of
utilization (not expenditure) estimates reveal that the elasticity may be positive or
negative depending on the data structure and econometric estimation method used.
Huttin (2000) for instance, finds positive income elasticity of utilization in the East
South Central and West South Central US regions while the elasticities in clusters within
the regions were either positive or negative.
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Demand for health care services rise with education and income. Higher
proportion of the educated in a population portends greater acquisition of health
knowledge and ability to produce health and use health care services more efficiently for
disease treatment and prevention, leading to less need for prescription drugs. Due to the
dynamic nature of health care demand, the current model includes one period lags in
income and the percentage of adults with post-secondary education. Moreover, the model
includes the uninsured population share, expected to correlate negatively with
prescription drug utilization, to control for the role of insurance in US healthcare.
State Variations
Although counties are the unit of analysis, here, state-specific dummies are included as
controls for Arkansas, Idaho, N. Dakota, S. Dakota, Tennessee and W. Virginia, (relative
to Washington). The dummies capture heterogeneous factors peculiar to each state (e.g.,
state-specific policies correlated with dug utilization), relative to the base state.
Box-Cox Regression Estimation Results8
The goodness of fit measures of the estimated CBC models incorporating habit
formation effect are significant improvements compared with those omitting the habit (or
inertia) effect9 Consequently, the ensuing discussions focus on the CBC models with
habit formation. The adjusted R2s are, respectively 0.65 (statistically significant F=25.58
at α=0.01 level) and 0.62 (statistically significant F=15.62 at the α=0.01 level) for the
low- and high -utilization models.
For the different utilization intensity groups I fitted separate CBC regression models. The
estimated optimal lambda (λ) values (see, Table 2) maximized the respective log-

An experiment in which data are not broken down by utilization intensity resulted in an estimated Box-Cox λ =
-0.16 (95 percent CI: -0.64, 0.33).
8

9

Likelihood ratio tests of hypothesis to compare models with habit formation (our preferred models) and similar
models estimated without habit formation for high-users and low-users rejected the fitting of restricted (i.e.
without habit formation) regression models to the data.
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likelihood functions for the models. The Box-Cox λ values are, respectively 1.00 (95
percent CI: 0.58, 1.42) and -2.66 (95 percent CI: -2.69, -2.63) for low- and high utilization models. The likelihood ratio hypothesis test of the low utilization model, for
evaluating appropriateness of the CBC λ compared with the a priori restrictive log,
linear, and inverse transformations of the dependent variable, rejected these nested forms
in favour of the linear functional form (i.e., the estimated CBC λ=1.14, 95 percent CI:
0.72, 1.57 is rejected in favour of λ=1). Interestingly, the high utilization model rejected
the various nested restrictive forms in favour of the estimated optimal λ of -2.66 (tratio=-170.36) of the CBC model.

Table 2. Box-Cox regression estimation results
Factors

Variables

Non-habit formation
model
LowHighusers
users
***
1.81
-2.86***
(5.82)
(-134.74)

Optimal Box-Cox10 𝝀
Habit effect

Log (prescription uset-1)
0.02**
(2.32)
0.005
(1.15)
0.004***
(5.79)
0.00006
(0.09)
-0.03***
(-5.22)
0.008***
(3.17)
-0.4***
(-3.57)
0.002
(0.38)
-0.004**
(-1.99)

Bad Health Index
Health and
lifestyle

% fair or poor health
PCP Density

Healthcare
access

Pharmacies per 100k
% Uninsured
% with post-secondaryt-1

Socioeconomics

Log (incomet-1)
% 65 years and older

Demographics

% Black

10

0.0005
(0.71)
0.0003
(0.93)
0.0001***
(5.70)
-0.00003
(-0.41)
-0.0006
(-1.20)
-0.0003
(-1.50)
-0.006
(-0.64)
-0.0002
(-0.64)
-0.0003**
(-2.34)

Habit formation
model
LowHighusers
users
***
1.00
-2.66***
(4.68)
(-170.36)
***
0.55
0.053***
(16.36) (11.59)
-0.003
-0.0009
(-0.32) (-1.19)
0.004
-0.00006
(1.18)
(-0.14)
**
0.002
0.00004
(2.45)
(1.36)
-0.0002 -0.00008
(-0.35) (-1.06)
-0.01
-0.002*
(-1.59) (-1.85)
.006*** -0.00003
(2.78)
(-0.14)
-0.04
-0.02
(-0.31) (-1.45)
0.003
0.00002
(0.66)
(0.06)
-0.003* -0.00004
(-1.87) (-0.44)

An experiment based on pooling the entire data (i.e. without partitioning by intensity of use) resulted in CBC
model estimate of λ = -0.16 (95 percent CI: -0.64, 0.33).
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Table 2. Box-Cox regression estimation results
Factors

Variables

Non-habit formation
model
LowHighusers
users
0.007**
-0.0005
(2.28)
(-1.46)
-0.006
0.005***
(-0.69)
(2.58)
**
-0.002
-.0002***
(-2.51)
(-2.94)
***
0.28
0.009
(3.62)
(1.002)
0.07
0.01
(1.01)
(1.59)
0.05
0.02***
(0.67)
(2.74)
**
0.14
0.02**
(2.02)
(2.29)
0.28***
0.004
(3.92)
(0.47)
0.16**
0.01
(2.02)
(1.19)
4.88***
0.13
(3.44)
(1.05)
254
173
.28(.25) .32(.28)
9.26***
8.65***
-3.55
-0.66

% Hispanic
% Female
% Rural
AR
ID
ND
State dummies
b

SD
TN
WV
Intercept

Statistics

N
R2 (Adj. R2)
F Statistic
Income elasticity at the
data means

Habit formation
model
LowHighusers
users
0.006** 0.0001
(2.19)
(0.27)
-0.004
0.004**
(-0.49) (2.58)
-0.0004 -0.0001
(-0.54) (-1.51)
0.26*** 0.01
(3.77)
(1.25)
0.01
0.009
(0.15)
(0.91)
-0.009
0.008
(-0.11) (0.87)
0.05
0.004
(0.76)
(0.49)
0.26*** 0.005
(3.96)
(0.51)
0.29*** 0.02*
(3.99)
(2.16)
1.42
0.34**
(0.9)
(1.98)
254
173
.68(.65) .66(.62)
25.6*** 15.62***
-0.35
-2.25

a

Classification at county level
Relative to Washington (WA) as the base state
c
t-ratio in parentheses
d
* p < 0.1, ** p < 0.05, *** p < 0.01
b

Health and Behavioural Factors
Accumulated habits (captured here using one-period lagged prescription utilization) is
positively and significantly associated with current prescription drug utilization in the
two estimated models. The CBC elasticity at the inertia data means is 0.05 for the low
users group and 0.39 for the high users group. The BHI effect is negative but not
significantly associated with prescription drug use in both utilization intensity models.
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Surprisingly, population percentage self-reporting fair or poor health is not significantly
correlated with utilization in low and high county groups.
Health Access Factors
Consistent with a priori theoretical expectation, the association of primary care physician
(PCP) density with the number of filled prescriptions is positive and statistically
significant in the low utilization group of counties. The utilization elasticity with respect
to PCP density is 0.07 in low- and 0.03 in high- user county models. However, utilization
correlates negatively with retail pharmacy density in both low and high utilization
models. As expected, the uninsured population proportion is negatively correlated with
utilization in both models but is statistically significant in the high-use counties model.
Demographic Factors
Ageing is not significantly correlated with utilization. However, utilization is negatively
correlated with Black ethnicity and positively correlated with Hispanic ethnicity in high
and low (statistically significant) user models. Rural population location is associated
with fewer prescriptions filled in both models; and the correlation of female population
proportion with utilization is, as expected, positive and significant in the high use model.
Socioeconomic Factors
One period lagged percentage of the adult population with post-secondary education is
negatively associated with prescription drug use in the high use counties but is positive
and significant in the low utilization model. One period lagged household income
correlates negatively with the number of prescriptions filled in the high and low use
models. The income elasticity of utilization estimates at the sample data means are,
respectively -2.25, and -0.35 in high- and low- utilization county models.
State-level Variations
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In the low utilization model, relative to the state of Washington, prescription drugs filled
in the states of Arkansas, Idaho, S. Dakota, Tennessee and W. Virginia are higher but
lower in N. Dakota. The difference is statistically significant in Arkansas, Tennessee and
W. Virginia. However, in the high utilization model all of the states filled more
prescriptions compared with the base state of Washington. This difference is, as
expected, statistically significant for W. Virginia.
Discussion
Health and Behavioural Factors
The habit effect is found to be the most important correlate of current prescription drug
use (standardized coefficient estimates are 0.71 and 0.64 respectively) in low-use and
high-use counties. The association with current year’s number of filled prescriptions is
positive and significant in both utilization intensity models, suggesting that prescription
drug demand tends to be habitual. The inertia elasticity of current utilization is 0.05 in
the low-use and 0.39 in the high-use counties. The significantly different elasticity
magnitudes is plausible if current prescription drug use reflects differences in illness
burdens, drug intervention for chronic health condition, or change in clinical guidelines
requiring multiple drugs or aggressive treatments. These results agree with the findings
of inertia effects in pharmaceutical expenditure in the OECD countries (Okunade and
Suraratdecha, 2006) and for individual level data (Leth-Petersen and Skipper, 2014).
Surprisingly, the two measures of health status in the model, BHI and percentage
of population self-reporting fair or poor health, are insignificant. This is plausible if
smokers, the obese or those reporting sub-optimal health are not sick to the extent of
requiring long term pharmaceutical care or if the effect of health status on current drug
use operates through ongoing utilization.
Health Access Factors
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Primary care physician (PCP) density and the number of filled scripts correlate positively
and significantly in low use counties model. The association is positive and insignificant
in high use counties. A positive association reflects the gate-keeping role of physicians as
prescribers. Different statistical significance of physicians for this role may represent
differences in healthcare use by the two groups of counties. This is further corroborated
by the 4 percentage point difference in the utilization elasticity with respect to PCP
density between the two utilization groups. This result is plausible if a higher percentage
of the population in high-use counties lack the usual and customary sources of care, and
they use the emergency department to obtain prescriptions. The absence of a coordinated
electronic health record system and lack of insurance coverage would make it easier for
this group to obtain prescription medicines. The difference could also reflect variations
in ability to pay if those in the low-use group are willing to pay higher co-pays for more
costly brand name prescriptions or respond more to direct-to-consumer-advertisement
(DTCA)11 and demand more brand drugs instead of the cheaper bio-equivalent generics
in their insurance plan’s formularies.
The uninsured population share correlates negatively with prescriptions filled
across the utilization intensity models. This significant association in the high-use model
accords with expectation as health insurance facilitates access to the gate-keeping PCPs.
According to the National Pharmaceutical Market Spend and Utilization Report 2015,
retail prescriptions filled grew 25.4 percent from 2013 to 2014 in the US states that
expanded Medicaid compared to 2.8 percent in states that did not (Novartis, 2015).
Demographic Factors

11

Robinson, Hohmann, and Rifkin, et al. (2004) discuss the potential effects of DTCA on the patient-physician
relationship.
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Although positive, there is no significant association between the elderly population
proportion and the number of filled prescriptions. Consistent with the literature, the
female proportion in the population correlates significantly and positively with per capita
prescription utilization only in the high use group. Elasticities of utilization with respect
to ethnic population groups indicate that a rise in the share of Blacks is associated with
less prescription use while a rise in the proportion of Hispanics correlates with greater
use.
Socioeconomic Factors
Finding negative association between one period lagged income and prescription drug
utilization in county groups of different utilization intensities is consistent with evidence
on social gradient in health. The negative elasticity implies that increased income shifts
leftwards the prescription drug demand. This is plausible, if secondary to an income rise,
consumers increasingly substitute more expensive brand name drugs for generics (which
is 90 percent of filled prescriptions in the US), or as income rises, increases in healthy
habits such as regular exercise (which is positively associated with income, Farrell and
Shields, 2002) and healthy diet augment the health stock and reduce needs for
prescription drugs.
The income elasticity of filled prescriptions differs significantly in low and high
utilization groups of counties. Estimated income elasticity of utilization in both intensity
groups suggest that prescription drugs may behave as inferior goods. This finding is not
surprising because a negative correlation is observed between lagged real income and the
number of scripts filled at retail. The estimated income elasticity is similarly signed as in
some past studies based on pharmaceutical expenditures or utilization (see, Appendix
Table 1). One of the income elasticities of utilization reported in Nianogo, Okunade and
Fofana et al. (2015) is negative. Expiration of blockbuster drug patents beginning 2011
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(DeRuiter and Holsten, 2012) could account for the negative income elasticity of
utilization as cheaper generics became increasingly available. It is important to
differentiate this income elasticity of utilization estimate from that based on expenditure.
The two components of an expenditure elasticity are quantity and quality (or price). This
point is important because the significantly less expensive generic drugs (which on
average cost nine times less than brand name drugs) account for about 90 percent of
prescriptions filled in the US. The difference in estimated income elasticities between the
two user groups may reflect differences between earned income and social support
income to the extent that the quantity or number of prescriptions filled is sensitive to
income source. If utilization is more sensitive to earned income, policies that raise earned
income would be useful for reducing the need for prescription drugs in the future. Such
policies, e.g., training and re-training may further reduce the need for social safety nets.
One period lagged population share with post-secondary education correlates
positively and significantly with prescription drug use in low utilization counties. This
may reflect greater adherence to treatment or investment in health.
State Variations
In the low-use counties, consumption of prescriptions is statistically greater in Arkansas,
Tennessee and W. Virginia relative to Washington while in the high-use counties model
consumption in W. Virginia is significantly greater. Arkansas, Tennessee and W.
Virginia Medicaid enrolees receive pharmaceutical benefits from state plans while in the
state of Washington this is provided by managed care organizations (MCOs) (National
Pharmaceutical Council, 2007). To the extent that MCOs have a tighter control over
utilization than state plans, the difference in utilization observed in the data reflects the
organization of prescription benefits. The difference across states may also reflect the
interaction of state level policies and other determinants of prescriptions use. The
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consistently higher consumption in W. Virginia may also reflect the position of W.
Virginia as one of the top ten states in Medicaid enrolment (Norvatis, 2015), and more
flexible prescribing/dispensing limits in Arkansas, Tennessee and W. Virginia relative to
Washington (National Pharmaceutical Council, 2007).
Conclusion
Healthcare technologies including prescription drugs are among the major drivers of the
rising US healthcare spending. As such, containing costs remains a current public policy
debate and this continues to justify studies on the correlates of healthcare services use.
Studies on prescription utilization are rare compared with those based on expenditures.
This study contributes to the literature on the correlates of prescription drug utilization
by analysing 2012 prescription demand data of the US counties partitioned into two
intensities of use. The study innovations include: (a) introducing inertia as a core
determinant; (b) partitioning utilization data and separately modelling them for the above
(high-use) and below (low-use) average groups of counties to elicit potential differences
in the economic nature of prescription commodity; and (c) fitting the a priori flexible
Box-Cox regression model, rarely entertained for modelling prescription utilization data.
The high-use group of counties data rejected the fitting of the a priori restrictive
functional form models but a linear transformation model is optimal for the low-use
group of counties.
Compared with models without habit formation, models including the
theoretically justifiable habit formation determinant have a better fit and lead to different
conclusions. Past use of prescription drugs (capturing inertia), unlike primary care
physician density in models without habit formation, is found to be the most important
correlate of current period utilization and the role of other determinants depend on the
data structure. This study demonstrates the importance of including inertia in healthcare
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use models and has implications for policymaking12. It suggests that cost control policies
account for differences in the correlates of prescription drugs utilization between
counties with varying intensities of use; and that demand side policy targets, including
health education and promotion, may be effective utilization control strategies.

12

While having more data cross-sections to cover the entire 50 states is desirable, the cost of implementing that
is prohibitively expensive thus presenting a limitation of the generalizability of our study.
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CHAPTER 3
SOCIOECONOMIC STATUS AND CHILD HEALTH OUTCOMES IN NIGERIAN
HOUSEHOLDS: EVIDENCE FROM DEMOGRAPHIC
AND HEALTH SURVEYS
Introduction
The need to better understand the determinants of population health outcomes continues to
motivate investigations on the relationship between household socioeconomic status (SES)
and population health. Past studies yield estimates of income or social gradient in health
(Marmot et al., 1978; Case et al., 2002; Kuehnle, 2014) which tend to be positive (i.e.,
relative to those with lower socioeconomic profile, wealthier population segments report
better health, live longer and suffer less severe chronic illnesses). The studies also explore
channels through which this relationship occur. Moreover, population health studies provide
opportunities for the planning of human capital growth policies in hopes of fostering
sustainable economic growth (Case, Fertig and Paxson, 2003; Khanan, Nghiem and
Connelly, 2009). SES measures include income, expenditure, wealth, occupation of
household members, parental education attainment (Shavers, 2007) and maternal labor force
participation (Mugo, 2012). Population health measures in past studies include mortality,
morbidity, and risk factors while individual health are self-reported or captured using
anthropometrics, among others.
A familiar challenge in studies of the social gradient in health is endogeneity arising
from measurement error, unobserved heterogeneity and simultaneity between the measures of
health and income. Although income may determine health status, household head health
status may simultaneously determine income, especially when health shocks affect the
productivity and income earning potential. To circumvent endogeneity, previous studies used
child health status as a proxy for household health because child health often correlates with
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adult health status (Contoyannis and Dooley, 2010). Moreover, children are unlikely
contributors to household economic welfare. Although child health is an unlikely determinant
of household income, a prolonged illness requiring intensive care may negatively affect
parental incomes if seeking healthcare for the child substitutes for paid work. This would be
problematic when capturing household socioeconomic status using current income.
Using National Demographic and Health Surveys (NDHS), the present work
exploring the social health gradient in Nigeria1 makes new contributions to the relevant
literature. The first is estimating a socioeconomic model of child health production in
Nigeria, a developing African country. Second, I estimate returns to maternal childcare
experience (as far as I know, this is the first paper to capture the ‘maternal learning’ effect in
a model of household health production). Third is the analysis of a larger and more recent
individual level data pooled over three waves (1999-2003, 2004-2008 and 2009 - 2013) of the
National Demographic and Health Surveys (NDHS) spanning fifteen years. Fourth, to reduce
endogeneity of the SES measures, I control for household wealth a priori by partitioning the
data into above and below the median ‘wealth index factor scores’ and then estimating a
health production model for each wealth group. Finally, I estimate the association between

1

Nigeria has 36 states, a centrally sited capital territory, population of 170 million, and the largest economy on the
African continent. Nigeria comprises six, internally homogeneous, geopolitical zones with mainly political
importance. The country’s health care system is a public-private mix in provision and financing. Years of neglect
of the health sector by various administrations in the post-independence era culminated in the significant
deterioration of health system infrastructure and poor health indices including high infant and maternal mortalities
and a low life expectancy of 47 years for males and 48 years for female in 2000. The World Health Organisation
(WHO) also ranked the overall performance of Nigeria’s health system 187th among the 191 member states of
the organization (WHO, 2000). The return to a democratic system of governance in 1999 placed health high on
the policy agenda leading to sector-wide reforms including healthcare financing (FMOH, 2004). Significant
improvements occurred in immunization rates and life expectancy at birth, which rose from 46 years in 1999 to
52 years in 2012. While Nigeria’s GDP has gradually risen in the last ten years (mostly from rising oil exportation
revenues), only a modest change in health expenditure has occurred.
Nigeria and other UN member countries in 2000 committed to the Millennium Development Goals (MDGs) –
a set of eight goals agreed upon to meet the needs of the world’s poorest by 2015. Committing to the MDGs also
escalated the relative importance of health in the public policy agenda. Progressive monitoring reports on the
MDGs indicated Nigeria and most African countries would not meet the goals on time. Our study can, therefore
inform evidence-based policy formulation for the post-MDG period.
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parental education (as education correlates well with wealth and income) and child health
within each wealth class.
Most of the published relevant studies are informative on the socioeconomic gradient
largely for the OECD countries (Kuehnle, 2014). An information gap exists in similar studies
on the developing countries (Shariff and Ahn, 1995; Lavy et al, 1996). More specifically,
while there are limited studies on the African countries, very little currently exists in
economics on the association between socioeconomic status and child health in Nigeria using
the latest national survey data waves. Significant socio-cultural and economic differences
between Nigeria and other African countries naturally limits generalizing past findings from
other countries. In this paper, I find positive effects of maternal education on the three
measures of household health status (height-for-age, HAZ; weight-for-height, WHZ; and
weight-for-age, WAZ) when fitting the model to data of richer SES and on two measures for
data of the poorer SES. Surprisingly, I detect no statistically significant effect of paternal
education in these models.
The rest of this work proceeds as follows. Section 2 surveys the literature, section 3
describes the analytical framework and an empirical strategy, section 4 focuses on the data
and describes the variables used in empirical econometric modelling, and section 5 presents
the results for discussion in section 6. Section 7 concludes with policy implications of the
findings.
Literature review
This study falls in the broad group of literature on the determinants of health. A subgroup to
which this study is related is estimating the contribution of inputs to child health production.
Following Grossman’s (1972) health capital model and Marmot’s (1978) observation of a
social gradient in health, extensive efforts continue to motivate studies on the determinants of
child health. These studies aim to improve our understanding of the determinants and suggest
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policies for improving population health. Mosley and Chen (1984), for example, proposed an
analytical framework comprising five categories of variables, which directly affect child
health and survival. They argued that broad categories of factors - maternal factors,
environmental contamination, nutrient deficiency, injury and control of personal illness- act
as intermediate or proximate variables through which distal factors operate to influence child
survival. Socioeconomic determinants of child health, grouped into three, namely,
individual-level factors e.g., parental productivity; household level variables e.g., wealth or
income; and community level variables reflecting the ecology, and the political and health
systems, fall within the distal group of variables affecting health status.
Past studies of the income gradient have used macro and micro level datasets. Macro
level studies measure economic conditions using, e.g., unemployment rate, GDP (Ruhm,
2000, 2002, and 2005; Anyanwu and Erhijakpor, 2007; Goryakin and Suhrcke, 2014), private
and public health expenditure (Chen, 2013), Gini coefficient and extreme poverty rate (e.g.
Shavers 2007), and aggregate measures of population health including mortality, morbidity
and lifestyle/behavioural risk factors.2 However, macroeconomic studies may mask local
variations and therefore provide inaccurate evidence for targeting resources at population
sub-groups. Lindo (2015) compares results of income gradient studies at various levels of
data aggregation. He concludes that micro level analyses produce precise estimates and are
better at detecting a statistically significant effect. Therefore, policy makers need micro level
information to inform resource allocation decisions.
There is a large body of micro level studies (e.g., Case et al, 2002, Chen et al, 2006,
Currie et al, 2007, Propper et al, 2007, Case et al, 2008, Allin and Stabile, 2012, Kruk, 2012,
Apouey and Geoffard, 2013 and Kuehnle, 2014) relating household socioeconomic
conditions to health status in high income countries. Similar studies on developing countries

2

For instance alcohol consumption, physical exercise and smoking.
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are sparse. Consequently, this study focusses on Nigeria, a lower middle income country for
which limited evidence currently exists in economics literature. To shed development country
perspectives, I briefly review below studies on Brazil, Ghana, Indonesia, Kenya, and
Uganda.3
Cameron and Williams (2005), using panel survey data, finds positive health-income
gradient for Indonesian children. The measure of health status is self-reported health in
children ages 11-14 years and parent-reported health for younger age groups. They did not
find a change in the slope at older ages unlike most studies of the developed countries.
Robustness checks involved nurse assessed health status but the outcome of such assessment
would naturally vary among nurses. Thomas, Strauss and Henriques (1991) analyzes Brazil
Demographic and Health Surveys. They partitioned data into rural and urban sectors and
estimated separate models of child (proxy for household) health production. They find a
highly significant positive impact of maternal and paternal education on height-for-age for
children in rural and urban sectors of Northeast Brazil. In the rural sector, a child’s height
increases by about 0.5 percent and 0.14 percent with each additional year of mother’s and her
partner’s education respectively. In the urban sector, the effects are 0.28 percent and 0.21
percent respectively. They also detect a linear relationship between mother’s education and
child’s height-for-age in rural areas, but the relationship is quadratic in the urban areas. The
study concludes that maternal access to information explains the impact of maternal
education on child (household) health. Moreover, Thomas (1994) finds a positive relationship
between maternal education and child health in the U.S., Brazil and Ghana with gender
variation. In particular, across the three countries the mother’s education has a greater impact
on the daughter’s height while father’s education has a greater effect on the son’s height.

3

An earlier draft of this paper included an exhaustive review of evidence from developed countries. Since past
study findings from the developing countries would be more relevant for our current work, we follow Janet
Currie’s comment to limit literature review to those of the developing economies.
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Ghanaian women with more education than their husbands have a greater effect on the
daughter than on the son’s height.
Lavy et al. (1996) studies the relationship between quality of health care, and child
survival and health outcomes in Ghana. They find drug availability and sanitary environment
to confer positive effect on height-for-age while detecting no statistically significant effect of
maternal education on child health. Shariff and Ahn (1995) analyzes data on children 0-5
years from a household DHS in Uganda in the 1980s. Using two stage least squares approach,
they find casual effect of maternal education on anthropometric indices of children and a
positive and significant relationship between maternal education and height-for-age while,
although positive, the effect on weight-for-height was insignificant.
Mugo (2012) analyzes household data from a Kenyan household survey to study the
association between maternal labor force participation and anthropometric measurements in
Kenyan children aged 0-5years. This study employing instrumental variable estimation
reports a positive but insignificant effect of maternal labor force participation on height-forage and weight-for-height. The study does not include children age 0-6 months, as their
height is not measured. Since neonatal mortality contributes significantly to infant mortality
excluding children age 0-6 months may lead to loss of vital information on health status of
children in the first year of life. Moreover, the WHO and CDC recommend measuring the
supine length of children age 0-2 years. Whereas the convention is to compare with the WHO
(2006) standardized reference, using the average Kenyan child as study reference limits
inference of their study findings. Their instrumental variables are weak but relevant and
valid.
Some studies of income gradient in Africa focus on specific disease conditions.
Forston (2008) studies the socioeconomic gradient in HIV/AIDS in five African countries
using DHS 2003 data for Burkina Faso, Cameroon, Ghana, Kenya and Tanzania. Using
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education and wealth defined as the count of household assets to capture socioeconomic
status, they report positive education gradients in all countries but the wealth effect depends
on the measure used.
The extensive literature reviewed shows the existence of significant research interest
in estimating the social or income gradient in health development. Many of these studies
however, contend with the problem of endogeneity, especially due to simultaneity of income
and health status. With this in mind, I propose handling the endogeneity problem by
controlling for wealth a priori.
Theoretical model and empirical strategy
Following Lavy et al. (1996), I estimate a utility maximization model of household resource
allocation decision with health status of members as an argument. The household derives
utility from consumption of commodities (C), services (S), leisure (L), and the health status
(H) of members. I express the household’s utility function as:
U = f (C, S, L, H)

(3.1)

The household derives utility from maximizing child health status (using anthropometrics)
which serves as a proxy for the household health in the present model.
Individual Child Characteristics
Individual child characteristics including child’s age, gender, birth weight and succeeding
birth interval are determinants of child health status. A child’s age generally correlates with
health status because children gradually develop immunity and become less vulnerable to
infections with age. Variation in health status with age also reflect differences in age-specific
care needs including nutrition. Health status of children born healthy should improve with
age. Gender differences in child health status exist with female children healthier than males.
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This, perhaps, is a consequence of genetic variation or sex-biased care from parents and
family members4.
Child health in-utero also determines health in childhood. Depending on the mother’s
health, the child acquires nutrients necessary for optimal growth at different ages. Intrauterine
growth retardation and low birth weight may increase the risk of illnesses during childhood
further delaying a child’s growth. Theory predicts that birth-weight within the normal range
is positively correlated with health status (Currie, Stabile and Manivong, et al., 2010).
Preceding or succeeding birth interval may also affect child health production. Giving
birth to children in quick succession may deprive both living and unborn children of adequate
care and nutrients. For a child, conception or the arrival of another child may reduce the care
the child gets from the parent and this may adversely affect the child’s health production. For
the unborn child, a pregnancy soon after a birth prevents the mother from regaining
physiologic levels of nutrients necessary for the optimal growth of the unborn child. Thus,
short birth intervals may adversely affect both production of child and maternal health.
Parental Characteristics
Parental characteristics in the present model include maternal and paternal formal education
and returns to the maternal experience of childcare. Parental education reflects returns to
human capital accumulation and access to resources and wealth. The better educated the
parents are, the better able they are at acquiring knowledge useful for production of child
health. The parents’ education also correlates with wealth and access to health care resources.
However, increasing parental education is also associated with a rising opportunity cost of
childcare and this may adversely affect health production. The return to maternal childcare

4

World Bank data indicate a consistently higher infant mortality rate and prevalence of malnutrition in male than
female children. Thomas (1994) analyzes demographic and health surveys of Brazil, Ghana and the US and finds
variations in household resource allocation which depends on the child’s and the parent’s gender. In particular,
they find maternal education has a greater effect on daughter’s than son’s height while paternal education has a
greater effect on the son’s height.
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experience is also a measure of human capital accumulation (or learning), i.e., knowledge
acquired by the mother by virtue of having given birth to and taken care of previous babies
and children. This measure will be important in mothers who have had children in the past.
Although in the cultural context of Nigeria, extended family members especially females
assist in the care of children and so a first-time mother may have some experience caring for
children. However, the dataset does not include this information and so I assume that only a
woman who has had a child in the past has some experience in childcare.
Household Characteristics
Household characteristics included in the model are size, gender of the household head and
wealth. Increasing wealth is positively associated with better health and is the main theme of
this paper. The gender of the household head may also matter for child health as this may
capture the differential preference for child health production between a household headed by
a male and that headed by a female (Thomas, 1994). In most cultures in Nigeria, females tend
to have a higher preference for childcare and be better at child health production. In Nigeria
however, a female household head usually implies a single parent household and since
females generally earn less than males, a female-headed than male-headed household may be
poorer and thus more likely to suffer poorer health. The size of the household may also affect
health status. Household size in Nigeria may reflect wealth or cultural practices e.g. in
polygamous families. Wealth (or resources) per capita decrease with increasing household
size and thus a larger household size is expected correlate negatively with health status.
Environmental Characteristics
Environmental characteristics include factors related to the geopolitical area of residence, as
these are heterogeneous sub-divisions within the country. For instance, the northern region of
the country has poorer health and education indices than the southern region. Indices may
vary within sub-regions but sub-regions are generally more homogeneous. Area of residence
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is rural or urban. Rural areas tend to have more poor people and poorer access to health care
and educational resources that are inputs in the production of health. Although urban areas
are expected to provide better health due to availability of pipe-borne water, better sanitation,
access to specialist health care etc., factors in the urban centers, e.g., noise and environmental
pollution, and excessive heat due to radiation from built up places may adversely affect
health. Environmental factors as defined in the model also include unobservable measure of
access to health services, which is not included in the variable representing rural residence
(i.e. rural represents factors other than access to care). Although farming is prevalent in the
rural areas, poor knowledge of optimal diet and balanced nutrition may still adversely affect
the health of the inhabitants of a rural location. Thus, I expect that residing in the northern
part of the country or in a rural area will be associated with poorer health status.
Time
Also included is an indicator for time in the production of health. That is, being in a particular
survey cohort may correlate with variation in health status perhaps due to technology
advances and other unmeasured but correlated factors over time.
Akin to Currie and Stabile (2003), I estimate a health production function of the form:
Y = f (I, M, P, HH, E, T, ϵ)

(3.2)

Where, Y is the child’s health status. I is a vector of individual child characteristics such as,
age, gender, birth interval and birth-weight. M and P respectively, are the vectors of maternal
and paternal characteristics, including maternal education, returns to maternal experience of
childcare and paternal education. HH is a vector of household characteristics including
household size, wealth and gender of household head. E is a vector of environmental
attributes including rural or urban location, geopolitical zone of residence, and health services
access directly affecting child health. Finally, T is a time dummy capturing the survey cohort
and ϵ is the random error term.
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Specifically, I estimate the following equation for the data pooled across three survey waves:
Yit = β0 + β1ln(MATEDUCit) + β2ln(BEXPit) + β3ln(PATEDUCit)
+ β4ln(BIRTHWGTit) + β5(FEMALEit) + β6ln(AGEit) + β7(BIRTHINTit)
+ β8ln(HHSIZEit) + β9(FEMALEHHit) + β10(RURALit) + β11(REGIONit)
+ β12(POORit) + β13(YEARt) + ϵit

(3.3)

Where Yit represents a measure of health outcome (HAZ, WHZ, and WAZ), ϵit is a random
error term reflecting unobservable heterogeneity in individual health, while β’s are
parameters of the model. Parameter estimates of interest are the effects of parental education
and the returns to maternal childcare experience.
To reduce endogeneity due to reverse causality between health status and household
wealth, I partition the study data into two – above and below the mean wealth factor score
and estimate Eq. (3.4) for jth wealth group (j=1,2).
Yitj = β0 + β1ln(MATEDUCitj) + β2ln(BEXPitj) + β3ln(PATEDUCitj)
+ β4ln(BIRTHWGTitj) + β5(FEMALEitj) + β6ln(AGEitj) + β7(BIRTHINTitj)
+ β8ln(HHSIZEitj) + β9(FEMALEHHitj) + β10(RURALitj) + β11(REGIONitj)
+ β12(YEARtj) + ϵitj

(3.4)

Eqs. (3.3) and (3.4) are estimated using OLS regression. I am interested in both maternal and
paternal education since 86 percent of the sample have both parents while about 10 percent
are female headed5. Eq. (3.4) enables understanding of the relationship between household
health and SES within each wealth group. Previous work (e.g., Currie and Stabile, 2003;
Shavers, 2007) demonstrate that parental education usually correlates highly with wealth.
Moreover, parental education is a less volatile and a better measure of SES than income or
wealth and child health is unlikely to determine parental education. I obtained the alternative

5

We excluded the interaction effect of maternal and paternal education from this specification because it lacks
statistical significance.
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measures of child health status from the dataset that have been normalized thereby making
OLS estimation suitable for the empirical model. Unobserved heterogeneity remains a
possible source of endogeneity but by adopting the determinants of child survival approach
the model includes as many control variables as possible to reduce this tendency
significantly.
Data and Variables
Data used are from three editions of Nigeria Demographic and Health Survey (NDHS).
MeasureDHS/USAID collaborates with more than 90 countries to conduct household surveys
and disseminate data every five years since 1984. NDHS are cross-sectional surveys for
collecting information on household background characteristics, family planning,
reproductive history, maternal and child health, gender, HIV/AIDS, malaria, and nutrition.
Data are pooled over three waves (1999-2003, 2004-2008 and 2009 - 2013) of the
National Demographic and Health Surveys (NDHS) spanning fifteen years. The surveys are
nationally representative and obtain information on all individuals who usually live in or
spent the previous night (before a survey was administered) in a household. Participating
households were selected based on two-stage stratified cluster sampling procedure, which
initially samples clusters with a probability6 followed by systematic random sampling of
households from each cluster. All females age 15-49 years in a selected household were
interviewed. The data were re-coded prior to dissemination to facilitate analysis. The children
recode (KR) dataset from each of the three waves of the NDHS are pooled and analyzed here.
The children re-code dataset has information on all children born during the 5-year
period preceding a survey (i.e., children age 0-59 months). The study data includes 66,158

6

Clusters selected from among the list of enumeration areas previously developed for population
censuses in the country.
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observations comprising DHS-2003 (6029 observations), DHS-2008 (28,647 observations),
and DHS-2013 (31,482 observations).
Alternative measures of the dependent variable:
Child Health Status:
I use three measures of child health status representing varying degrees of severity and
chronicity. They are length/height-for-age (HAZ) (supine length below the age of 2 years),
weight-for-age (WAZ) and weight-for-height (WHZ), measured in z-scores or standard
deviations and are continuous, and compare distributions of child’s height and weight by age
and gender with the WHO (2006) reference growth curves for the respective measures. Each
measures cumulative health reflecting different lengths of time (Thomas, 1994). Height-forage (HAZ) measures the degree of linear growth delay or stunting and is an indication of
cumulative growth delays (due to malnutrition and poor health) over the long term. WHO
definition of stunting is HAZ below -2 standard deviations from the median of WHO
reference.
Weight-for-height (WHZ) measures delays in body mass or wasting due to malnutrition
or poor health. It is a measure of acute health shocks or health over a short run. Weight-forage is a combination of the previous two and measures the degree of underweight by age.
Weight-for-age (WAZ) or underweight represents values less than -2 standard deviations from
the appropriate reference values (Blossner and de Onis, 2005). The WHO (2006) reference
child is derived from the multicentre growth reference study (MGRS) which used primary
growth data from 8500 children from widely different ethnic backgrounds and cultural
settings in countries including Brazil, Ghana, India, Norway, Oman and the U.S.
Although usually inferred in the literature as evidence of malnutrition, Mosley and
Chen (1984) argues that these are measures of overall health status since growth delays in
children may be due to a multiplicity of factors including diet and nutrition. They further
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argue that growth delays occur along a spectrum which includes stunting, wasting and
underweight and which has death as its worst outcome. These measures are more objective
and appropriate measures than self-reported health or physical examination by a physician7.
Independent Variables:
Socioeconomic Status
The main measure of household socioeconomic status is parental education since I already
control for wealth by partitioning the data according to wealth groups. Parental education has
been used in the literature (Currie and Stabile, 2003; Forston, 2008) as it correlates well with
household income or wealth. Both maternal and paternal education in years correlate well
with the measure of household wealth included in the dataset. Both are included in the model
in their logarithmic functional forms. Parental education is also less vulnerable to child health
shocks unlike income or wealth, which may be liquidated to defray the cost of accessing
health care. Current income may also be difficult to measure in a developing country context
like Nigeria where individuals in households may have multiple sources of income and
culturally, people are averse to divulging information on income (more so to strangers e.g.,
survey personnel). Household income figures in surveys may also be inaccurate as
individuals in the household may not all contribute to household wealth (Rutstein et al,
2004). Parental education is also less vulnerable to endogeneity due to reverse causality as
the child’s health is unlikely to determine parental education.
The wealth index score is included in the survey dataset, and is computed from
household durable assets using principal component analysis (Filmer and Pritchett, 2001)8.

7

Measurements, including height and weight, that go into estimation of height-for-age and weight-for-height may
however be measured with error.
8
Detailed information on construction of wealth index is provided by Rutstein, S.O. et al, (2004). The DHS Wealth
Index downloaded from the DHS web. See also National Population Commission (NPC) [Nigeria] and ICF
International. 2014. Nigeria Demographic and Health Survey 2013. Abuja, Nigeria, and Rockville, Maryland,
USA: NPC and ICF International.
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The division into wealth quintiles released with the data does not have enough observations
to allow estimation in the poorest quintile. To facilitate the analysis, I divided the dataset into
above (richer) and below (poorer) the median wealth index factor score.
Control Variables
The control variables are wealth group and a set of variables, which control for maternal,
paternal, child, environmental characteristics and a cohort dummy9. Some of these are
proximate factors while others are distal and act through the proximate determinants of child
health. Child’s age, birth weight and household size are included in the models in logarithms.
I also include a control factor to measure the return to maternal experience in
childcare. This measure, included in its logarithmic form is the computed difference between
maternal age and age at first birth. Parental employment is not included as this also correlates
well with educational attainment. As far as I am aware, this is the first study to consider the
effect of returns to maternal childcare experience.
Environmental controls include the type of place of residence and region of residence.
I use these to measure environmental influence, which apart from region and local residence
includes the availability of skilled health care services. The NDHS groups type of place of
residence into rural or urban using a cut-off of 20,000 residents. Population greater than
20,000 is classified as urban, and rural otherwise. The region of residence refers to the
geopolitical zone of the country where the household resides. Table 3 presents a definition of
the variables. Prior to econometric estimation, I recoded all extreme data values as missing
rather than deleting an entire record. I limited the maximum value of birth-weight to 4kg, as
some of the values in the original dataset were not reasonable.10 Consequently, the average

9

Only the cohort dummy for 2008 is included. The 2013 cohort dummy is highly correlated (0.8) with this and
dropped from the estimation due to collinearity.
10
Prior to this exclusion, maximum value of birth-weight was 8.8kg.
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birth-weight in the sample is 3.12kg which is comparable with figures in the published
literature for Nigerian children (e.g. Mutihir and Pam, 2006; Swende, 2011).
Table 3: Definition of child and household variables

Child factors

Maternal factors

Paternal factors
Household factors

Variable
Female
Age
Birth weight
Birth interval
Mother’s age
Mother’s schooling
Childcare experience
Father’s age
Father’s schooling
Household (HH) size
Female HH head
Richer

Environmental factors

Dependent variable

Poorer
Rural (base is Urban)
Northcentral

Definition
Child is female (1=yes)
Child’s age
Succeeding birth interval
Years of maternal education
Length of time between first and
most recent birth (or current
pregnancy)
Years of paternal education
Number in household
Female
headed
household
(1=yes)
Above
median
household
wealth
Below median household wealth
Rural residence dummy (1=yes)
Regional dummies

Northeast
Northwest
Southeast
Southsouth
Southwest (base region)
Height-for-age (z-scores)
Weight-for-height (z-scores)
Weight-for-age (z-scores)

To construct the measure of maternal experience, we limited the lowest value to zero to
eliminate negative values due to approximation during data entry in the original dataset.
Results
Table 4 containing the descriptive summary of the data suggests that in general, there is a
statistically significant difference between both wealth groups. About 49 percent of the
children in the data pool are females, the average age of children is 1.9 years and 86 percent
live with parents. The mean height-for-age (HAZ) z score is -1.43 standard deviations from
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Table 4: Households summary statistics: mean (standard error), difference of means (t-ratio)

Child factors

Variable
Female gender
Age
Birth weight

Parental factors

Mother’s age
Mother’s schooling
Childcare experience
Father’s age
Father’s schooling

Household
factors

Household size
Female HH head

Environmental
factors

Rural
Northcentral
Northeast
Northwest
Southeast
Southsouth
Southwest

Anthropometric
measures

Height-for-age
Weight-for-height
Weight-for-age
Stunting
Wasting
Underweight

Pooled
0.49
(0.5)
1.93
(1.43)
3.12
(0.53)
29.33
(7.03)
4.51
(5.11)
10.13
(6.86)
40.03
(10.59)
6.02
(5.75)
7.06
(3.62)
0.1
(0.3)
0.7
(0.46)
0.16
(0.37)
0.22
(0.41)
0.30
(0.46)
0.09
(0.28)
0.12
(0.32)
0.12
(0.32)
-1.43
(2.03)
-0.42
(1.64)
-1.13
(1.42)
0.26
(0.44)
0.62
(0.49)
0.17
(0.38)
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Above
0.49
(0.5)
1.93
(1.43)
3.13
(0.53)
29.61
(6.62)
7.28
(5.17)
9.33
(6.59)
39.73
(9.99)
9.12
(5.27)
6.76
(3.69)
0.13
(0.33)
0.47
(0.5)
0.19
(0.39)
0.13
(0.33)
0.18
(0.38)
0.13
(0.34)
0.18
(0.39)
0.2
(0.4)
-1.05
(1.91)
-0.34
(1.54)
-0.84
(1.34)
0.2
(0.4)
0.66
(0.48)
0.13
(0.33)

Below
0.49
(0.5)
1.92
(1.43)
3.00
(0.58)
29.04
(7.40)
1.74
(3.20)
10.93
(7.03)
40.33
(11.13)
2.97
(4.40)
7.37
(3.51)
0.07
(0.26)
0.92
(027)
0.14
(0.34)
0.32
(0.47)
0.42
(0.49)
0.05
(0.21)
0.05
(0.22)
0.04
(0.19)
-1.87
(2.08)
-0.52
(1.74)
-1.45
(1.44)
0.31
(0.46)
0.58
(0.49)
0.21
(0.41)

Difference
0.001
(0.37)
0.002
(0.24)
0.13***
(6.26)
0.57***
(10.45)
5.54***
(165.70)
-1.60***
(-30.19)
-0.602***
(-7.12)
6.15***
(159.89)
-0.62***
(-21.97)
0.06***
(24.02)
-0.45***
(-142.48)
0.05***
(18.25)
-0.19***
(-60.42)
-0.24***
(-70.16)
0.09***
(39.47)
0.13***
(54.45)
0.16***
(65.76)
0.82***
(42.94)
0.18***
(11.33)
0.61***
(45.81)
-0.11***
(-31.26)
0.08***
(20.81)
-0.09***
(-30.52)

the WHO reference, mean weight-for-height (WHZ) z score, -0.42 standard deviation from
the WHO reference and weight-for-age (WAZ) Z score is -1.13sd from the median value of
the WHO reference child.
Effect of Family Socioeconomic Status on Height-for-Age (stunting)
For the wealthier household group, a percentage rise in the number of years of maternal
education is associated with 0.006sd increase in height-for-age and 0.01sd increase for the
poorer households. These effects are statistically significant. Surprisingly, paternal education
has no statistically significant effect in any of the models. Statistically insignificant negative
returns to maternal ‘child care’ experience is observed for households in both wealth classes.
Child’s birth-weight has positive and significant effects in the rich group (0.631). The
effect is negative and significant (-1.261) in the poor group. Birth interval has a negative and
significant effect in the rich sample (-0.155) but no significant effect in the poor wealth
group. Being female has a positive effect in the wealthier sample but no effect in the poorer
sample. Age has a positive and significant effect in the poor wealth band. The results are in
Table 5.
Residing in a rural environment relative to urban, has a statistically significant negative
effect on stunting in the rich sample (-0.344). Household size has positive and significant
effect in the rich sample (0.221). Having a female head of household has a negative and
significant effect in the rich wealth group. Relative to living in the SW zone, residing in the
NW is associated with statistically significant negative effect in the rich group. There is a
significant positive difference between children living in the SE (southeast) and SW
(southwest). Relative to 2003, being in the 2008 cohort is associated with worsening of
stunting in the richer group.
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Table 5: Height-for-Age (HAZ) model

Parental
factors

Pooled
0.657***
(0.12)
-0.044
(0.079)
0.073
(0.11)
0.483**
(0.227)
0.126*
(0.073)
-0.062
(0.148)
-0.185***
(0.055)
0.259**
(0.127)
-0.175
(0.112)
-0.03
(0.207)
-0.328***
(0.084)
0.151
(0.111)
-0.316*
(0.19)
-0.874***
(0.229)
0.194**
(0.098)
0.162
(0.117)
-0.197**
(0.077)
-2.81***
(0.47)
0.095
9.6***
1700

Mother’s schooling
Childcare experience
Father’s schooling

Child factors

Birth weight
Female
Age
Birth interval

Household
factors

Household (HH) size
Female HH head
Poorer household

Environmental
factors

Rural
Northcentral
Northeast
Northwest
Southeast
Southsouth

Time dummies

Year08_dummy
Intercept
R2
F Statistic
N

*

p<0.10, **p<0.05, ***p<0.01
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Above
0.621***
(0.126)
-0.02
(0.081)
0.143
(0.114)
0.631***
(0.24)
0.131*
(0.074)
-0.132
(0.15)
0.155***
(0.056)
0.221*
(0.128)
-0.231**
(0.111)

Below
1.024***
(0.391)
-0.044
(0.323)
-0.635
(0.472)
-1.261**
(0.52)
0.111
(0.382)
2.215**
(0.882)
-0.34
(0.275)
0.105
(0.813)
0.622
(0.583)

-0.344***
(0.086)
0.18
(1.114)
-0.258
(0.189)
-1.059***
(0.225)
0.222**
(0.1)
0.171
(0.118)
-0.204***
(0.078)
-3.023***
(0.48)
0.099
10.31***
1620

0.728
(0.568)
-0.219
(0.518)
-0.636
(0.993)
0.879
(0.954)
0.721
(0.606)
0.276
(0.838)
-0.623
(0.462)
-1.99*
(1.172)
0.262
2.33***
80

Effect of Family Socioeconomic Status on Weight-for-Height (wasting)
Table 6 presents the regression estimates for the pooled data and the separate wealth classes
of households. Maternal education has positive effects on WHZ, i.e., it reduces wasting in the
wealthier household group. There is no statistically significant effect of paternal education on
wasting and the returns to maternal childcare experience are not significant across the
models.
Birth-weight has positive effects in both wealth groups but this is only significant in the
richer wealth group model. Birth interval is negatively and significantly associated with WHZ
in the richer group. Living in the NC, NE, SE and SS geopolitical zones is not significantly
different from the SW while relative to living in the SW, wealthier children in the NW have
poorer WHZ scores. The cohort dummy for 2008 suggests that WHZ is better than 2003 for
both wealth groups.
Effect of Family Socioeconomic Status on Weight-for-Age (underweight)
Table 7 presents estimation results of the model with weight-for-age as the dependent
variable. Maternal education has a positive effect on weight-for-age in the rich (0.497) and
poor (0.611) samples. There is no statistically significant effect of paternal education or the
returns to maternal experience.
The effect of birth-weight is positive in the rich model (0.749) and negative in the poor
sample (-0.689). Child’s gender has no significant effect but age has a positive and significant
effect on WAZ in the poor sample model. Increasing birth interval is associated with a
negative effect in both wealth group models. Household size has a positive effect on
underweight in the rich wealth band (0.223). Rural (relative to urban) residence is associated
with a negative effect in the rich sample while there is no effect in the poor group model. NE
and NW residence are associated with poorer (relative to SW) effects among the rich. SS
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zone of the country has a more positive effect on weight-for-age relative to residing in the
SW.
Table 6: Weight-for-Height (WHZ) model

Parental
factors

Pooled
Above
*
0.191
0.195*
(0.098)
(0.102)
0.042
0.03
(0.064)
(0.066)
-0.137
-0.141
(0.09)
(0.093)
0.449**
0.54***
(0.19)
(0.207)
-0.093
-0.089
(0.062)
(0.063)
-0.009
-0.00
(0.11)
(0.113)
-0.094*
-0.093*
(0.048)
(0.05)
0.14
0.152
(0.103)
(0.106)
0.157*
0.223**
(0.093)
(0.097)
0.133
(0.153)
-0.061
-0.063
(0.071)
(0.073)
-0.001
-0.027
(0.095)
(0.097)
-0.221
-0.273
(0.159)
(0.166)
-0.969*** -0.958***
(0.215)
(0.217)
-0.066
-0.082
(0.082)
(0.085)
0.131
-0.118
(0.097)
(0.098)
0.333*** 0.316***
(0.063)
(0.065)
**
-0.966
-1.071**
(0.409)
(0.42)
0.053
0.052
***
4.58
4.54***
1700
1620

Mother’s schooling
Childcare experience
Father’s schooling

Child factors

Birth weight
Female
Age
Birth interval

Household
factors

Household (HH) size
Female HH head
Poorer HH

Environmental
factors

Rural
Northcentral
Northeast
Northwest
Southeast
Southsouth

Time dummies

Year08_dummy
Intercept
R2
F Statistic
N

*

p<0.10, **p<0.05, ***p<0.01
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Below
0.005
(0.338)
0.132
(0.318)
0.017
(0.315)
0.064
(0.439)
-0.169
(0.333)
-0.335
(0.607)
-0.115
(0.236)
0.165
(0.533)
-0.774*
(0.39)

-0.127
(0.323)
0.46
(0.493)
0.425
(0.562)
-0.753
(1.177)
0.354
(0.417)
0.745
(0.629)
0.705**
(0.305)
-0.459
(1.654)
0.205
1.51
80

Discussion of Results
Effect of Socioeconomic Status on Height-for-Age
Maternal education, our measure of household SES, has positive and significant effects in
both wealth groups confirming the presence of an income gradient in child health. The
steeper slope in the poorer wealth group suggests that the child health-income gradient is
more pronounced in the lower socioeconomic class. Surprisingly, paternal education is not
significantly associated with HAZ. This observation can be explained by the managerial role
played by the mother in Nigerian households. Although the male head is the main source of
household resources, day-to-day health care resource allocation decision is usually carried out
by the mother. This finding of a non-significant association in paternal education also
emphasizes the mother’s resource allocation role as the main determinant of child health over
the long term. A significant effect of maternal education may also reflect the mother’s ability
to complement the efforts of the male partner in gaining access to resources, which improve
child health. Complementarity may also be responsible for the finding of poorer health in
female-headed households. The positive effect of maternal education may also be explained
as a consequence of the increased ability of the mother to acquire information, which she
applies in child care.
The effect of the returns to maternal experience is negative in the partitioned models.
The magnitude of the effect gradually increases with wealth but none of this is statistically
significant. This negative return to experience may reflect the presence of an implicit
threshold below which maternal experience reverts to experience at first pregnancy. This may
be the case when longer birth intervals lead to long periods of maternal childcare experience.
Child birthweight behaves as expected with a positive and significant effect in the rich
group. Surprisingly however, a negative gradient is observed in the poor sample. Female
gender is positively associated with HAZ in the rich sample (where it is also significant). As
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expected, increasing age is positively associated with better health in children in the poor
group. Unexpectedly, longer birth interval is associated with poorer health in the rich sample.
Rural residence behaves as expected with a significant negative effect in the rich sample.
This negative effect in the rich group mirrors the known lack of or poor access to health care
resources in this environment.
Effect of Socioeconomic Status on Weight-for-Height
Maternal education has a positive effect in the rich group also indicating the presence of an
income gradient in short term child health. The observation adds to the evidence on the
importance of the mother’s role for child health and her ability to use acquired knowledge as
input in child health production. No significant relationship is observed between maternal
education and child health in the poor. Paternal education has no significant effect on child
health in both models. Here also, I do not find a significant return to maternal childcare
experience.
Birth-weight is found to be positive in the rich wealth band but no effect is observed
in the poor. Being female unexpectedly has no significant effect in both wealth groups while
birth weight is observed to exert positive effects in both wealth groups, which is only
significant in the rich. The child’s age and household size do not have statistically significant
effects but female-headed households are observed to be associated with a negative gradient
in the poor and a positive gradient in the rich.
The NW region experiences poorer short-term health than the SW region of residence
while there is no significant difference between the other geopolitical zones and the SW. The
finding of no difference between the NC and SW could be due to the heterogeneous
population structure of the NC region and, presence of educational institutions and
availability of health care services, which are similar to the SW.
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Table 7: Weight-for-Age (WAZ) model

Parental
factors

Pooled
Above
***
0.517
0.497***
(0.083)
(0.087)
-0.004
-0.00
(0.056)
(0.059)
-0.057
-0.021
(0.079)
(0.083)
0.596*** 0.749***
(0.186)
(0.189)
0.001
0.006
(0.052)
(0.054)
-0.063
-0.096
(0.102)
(0.103)
-0.175*** -0.155***
(0.04)
(0.041)
***
0.238
0.223**
(0.09)
(0.093)
0.004
0.015
(0.074)
(0.076)
0.068
(0.127)
-0.231*** -0.243***
(0.057)
(0.059)
0.088
0.087
(0.088)
(0.089)
-0.342** -0.343**
(0.133)
(0.14)
-1.166*** -1.267***
(0.164)
(0.17)
0.07
0.076
(0.072)
(0.074)
0.183**
0.18**
(0.078)
(0.08)
0.099*
0.083
(0.054)
(0.055)
-2.222*** -2.42***
(0.333)
(0.343)
0.124
0.129
***
12.37
12.21***
1700
1620

Mother’s schooling
Childcare experience
Father’s schooling

Child factors

Birth weight
Female
Age
Birth interval

Household
factors

Household (HH) size
Female HH head
Poorer HH

Environmental
factors

Rural
Northcentral
Northeast
Northwest
Southeast
Southsouth

Time dummies

Year08_dummy
Intercept
R2
F Statistic
N

Below
0.611**
(0.271)
0.076
(0.222)
-0.351
(0.287)
-0.689*
(0.38)
-0.061
(0.255)
0.953*
(0.524)
-0.293*
(0.162)
0.077
(0.418)
-0.175
(0.273)

0.324
(0.309)
0.19
(0.434)
-0.118
(0.472)
0.002
(0.553)
0.639
(0.391)
0.669*
(0.378)
0.095
(0.3)
-1.88
(1.583)
0.256
1.6*
80

*

p<0.10, **p<0.05, ***p<0.01

Effect of Socioeconomic Status on Underweight
The effect of maternal education on underweight indicates a clear pattern of a linear
relationship between child health and SES. The measure of SES has a positive effect on
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underweight in the two models estimated. The gradient is steeper for the poor. The positive
effect may be due to the mother’s ability to acquire knowledge and use this as an input in
child health production. The steeper slope among the poor also suggests a greater importance
of the gradient in the lower SES groups.
Maternal returns to experience has a negative effect on underweight in the wealthier
group. A possible reason for this may be that mothers in this wealth group are employed in
time consuming and well paid jobs. In addition, these mothers may also reside in an urban
area and encounter heavy traffic commuting to and from work. These factors increase the
opportunity cost of childcare and most mothers therefore entrust the care of their child to a
caregiver who is usually not well educated and may lack knowledge of proper childcare
practices. The cumulative effect of this is a worsening of the child’s health regardless of
mother’s experience in childcare.
Negative effects observed in the NE and NW regions, relative to the SW of Nigeria
probably reflects a perennial problem of poor education in the northern parts relative to the
rest of the country. The northern region has poorer health indices than the rest of the country
due to poor education and strong religious resistance to western healthcare services e.g.
immunization programs. Northern Nigeria is also home to cattle herdsmen who travel miles
on foot with their families while tending their cattle. The nature of this occupation reduces
the opportunity for formal education and access to health care services. The SS region is
observed in both models to have better health in the medium term compared with the SW.
Summary and conclusion
Study findings on the effects of socioeconomic status (SES) on child health can guide
improved resource allocation decision policies. Most existing evidence on the social gradient
in health are from the developed countries and few are from the developing countries of
Africa. These studies used child health as proxy for household health. The present study
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focusing on Nigeria used 1999-2003, 2004-2008, and 2009-2013 household data from
National Demographic and Health Surveys.
I estimated child health production models using pooled survey dataset partitioned
into wealth groups, and consistently found a positive effect of maternal education on child
health especially in the rich wealth sub-group of the data. Surprisingly, paternal education is
not a significant correlate of health in any of the estimated models. The measure of the
returns to maternal childcare experience is insignificant across the estimated models.
Residence in certain geopolitical zones correlates with household health conditions.
Research findings in this work confirm the existence of a social gradient in health for
Nigeria. With the country unable to meet the MDGs goals to reduce infant and under-5
mortality by 201511 (OSSAP-MDG, 2015), an implication of these findings is that child (and
population) health improvements can be achieved by directing resources to interventions
capable of improving maternal education, e.g., in the country’s NE and NW regions.
Targeting resources towards unmet targets in female education and empowerment within the
sustainable development goals creates an opportunity for the country in this regard.
Moreover, detecting variations in health gradients across the different household wealth
groups highlights the need to adjust policy interventions when targeting different SES groups.
Finally, future work should provide additional evidence on the shape of socioeconomic health
gradients for the other developing African countries, using their latest national survey data
waves.

11

Report downloaded from http://www.undp.org/content/undp/en/home/librarypage/mdg/mdg-reports/africacollection.html on November 10, 2016.
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CHAPTER 4
AN ECONOMIC MODEL OF TREATMENT ADHERENCE IN US CHRONIC
OBSTRUCTIVE PULMONARY DISEASE PATIENTS
Introduction
Chronic Obstructive Pulmonary Disease (COPD), a leading cause of death in the U.S.
and globally (WHO, 2016), is irreversible and causes progressive destruction of the lungs. It
occurs in two main forms--emphysema and chronic bronchitis--with symptoms such as
difficulty breathing and increased susceptibility to chest infections. The most common risk
factor is cigarette smoking (Hoyert and Xu, 2011). Usually associated with older age,
significant morbidity due to COPD has also been established in working age adults (Strassels
et al., 2001).
COPD exerts enormous economic burden on the U.S. health care system accounting
for significant resource use (Strassels et al., 2001). It causes greater impairment at work and
overall impairment compared with the general population (DiBonaventura et al., 2012a and
2012b). Exacerbations due to chest infection account for most of the resource use and high
costs associated with COPD (Andersson et al., 2002). Due to complexity of symptom
management (George, Kong, and Stewart, 2007), current treatment strategies focus on
slowing disease progression, relieving symptoms and increasing exercise tolerance (Global
Initiative for Chronic Obstructive Lung Disease, 2011).
Smoking cessation and annual influenza vaccination are two effective disease-slowing
treatments. Smoking cessation (Anthonisen et al., 1994) has also been shown to improve
symptoms (Buist et al., 1976) while annual influenza vaccination helps to prevent chest
infections. Medications may also be prescribed to relieve symptoms and reduce exacerbation.
The efficacy of smoking cessation and influenza vaccination for slowing down
disease progress is well known and proven (Sin et al., 2002; George et al., 2006; and Fletcher
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et al., 2011), but effectiveness depends on patient adherence to treatment advice (Marinker et
al., 1997). Adherence can thus be viewed as an investment in health and an important factor
in the study of clinical and economic outcomes in COPD. About 5 - 40 percent of hospital readmissions in COPD are reported to be associated with non-adherence to medication (Col,
Fanale and Kronholm, 1990; Sullivan, Kreling and Hazlet, 1990; and Dunbar-Jacob and
Mortimer-Stephens, 2001). Therefore, measures to improve adherence and reduce hospital
admissions can contribute to controlling the growth of high U.S. healthcare expenditures.
This paper aims to study the effect of adherence to treatment on the health stock in
U.S. adults with COPD. It contributes to the economic analysis of COPD and its treatment
options in three main ways. First, unlike previous studies in medicine and health services
research, this paper studies a health investment decision by focusing on the impact of
adherence to treatment on an economic outcome variable, the health stock of a COPD patient
as measured by the count of healthy days. Second, adherence to treatment is modelled as a
two-stage decision employing the double hurdle regression1 estimation method (Cragg 1971).
To my knowledge, the present effort is the first to follow this line of enquiry for COPD.
Third, unlike previous studies2, the study analyzes a large, nationally representative dataset
based on the 2011-2013 survey data of the Behavioral Risk Factor Surveillance System
(BRFSS) of the U.S. Centers for Disease Control and Prevention (CDC). The results show
that smoking cessation alone increases the probability of an effect by 3 percent and adds 0.5
healthy days in a typical month relative to current smokers who are not vaccinated.

1

The double hurdle (DH) model has been used in the study of healthcare topics including addiction and
smoking cessation (Jones, 1994); alcohol consumption (Aristei et al., 2008); demand in healthcare (Silva and
Windmeijer, 2001); female smoking and drinking (Madden, 2008); and household healthcare expenditure
(Okunade, Suraratdecha and Benson, 2010; Ogundari and Abdulai, 2014).
2

E.g., Balakrishnan and Christensen (2000) which uses data of elderly individuals enrolled in a health
maintenance organization.
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Full adherence increases the probability of an effect by 4 percent and 0.67 more days of good
health.
The balance of this paper is organized as follows. Section 2 surveys the relevant
literature. Section 3 discusses the methodology while results are presented in Section 4.
Section 5 discusses the results, and Section 6 presents conclusions, discusses limitations, and
offers policy suggestions.
Literature Review
Becker (1964) and Fuchs (1966) were among the earliest economists who studied the
health of individuals by incorporating health into a human capital model. Grossman (1972)
advanced the frontier of health research by studying the demand for health and viewing
health as a durable capital stock that produced healthy days. The study is built on the
foundation of two main strands of existing literature: the relationship between health and
productivity and economic impact of adherence to treatment.
Health and Productivity
Grossman’s (1972) model of demand for health proposes a view of health as both a
consumption good and an investment capital. As a consumption good, health is desired as a
requirement for carrying out daily activities including work and leisure. As an investment
capital, health can be considered as a stock of health capital from which flows a stream of
healthy days per unit of time. A higher health stock in period t-1 yields a stronger flow of
healthy days in period t. In this framework, inputs to health production (e.g., personal and
preventive healthcare services and healthy behaviors) increase the health stock. In COPD, it
can be hypothesized that smoking cessation and seasonal influenza vaccination can increase
the health stock.
In terms of health and productivity, Sin et al. (2002) analyzed the Third National
Health and Nutrition Examination survey (NHANES III) and found a lower likelihood of

54

labor force participation among individuals with COPD compared with the U.S. general
population. Fletcher et al. (2011) surveyed the literature on the personal, economic and
societal impact of COPD among working age population in the U.S., UK, Turkey, Germany,
Brazil and China. They found that quality of life decreased with increasing disease severity;
healthcare use cost $2,364 annually; and individuals with COPD retired on average 4 years
earlier than the general population.
Economic Impact of Adherence to Treatment
Adherence is defined as “the extent to which a person’s behavior coincides with
medical or health advice” (Haynes, Taylor, & Sackett, 1979; Horwitz & Horwitz, 1993).
Adherence3 to therapy is complex (Dunbar-Jacob & Mortimer-Stephens, 2001),
multidimensional (George, Kong, and Stewart, 2007) and determined by age, health beliefs,
experiences, and behaviors (Restrepo et al., 2008).
Many have studied the benefits of adherence to treatment. For example, Sullivan,
Kreling and Hazlet (1990) reported that 5.5 percent of hospital admissions were due to
prescription medication non-compliance. François-emery Cotté, and Gérard De Pouvourville
(2011) found the cost-effectiveness ratio of real-world adherence to dominate non-adherence
to persistent use of oral bisphosphonates in post-menopausal women in France. Rizzo, Abbott
and Pashko (1998) studied the relationship between adherence and labor productivity in the
U.S. and found net benefits to employers from having workers take prescription medicines
for their chronic illnesses and concluded the estimated benefits accrued to employers due to
lower absenteeism as a result of compliance. However, the study did not include COPD and
used dated data. Moreover, Cleemput, Kesteloot and DeGeest (2002) argued that most

3

Three types of adherence are identified in the literature including underuse, overuse and improper use.
Methods for measuring treatment adherence include medication adherence scales, pharmacy refill records, selfreported adherence and electronic monitoring. A comparison of these shows widely varying adherence rates
(Dunbar-Jacob, Burke and Rohay et al, 1996; and George, Kong, and Stewart, 2007).
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previous studies of adherence effects lacked rigor due to differences in the measurement of
adherence, costs and benefits.
Different from previous studies, this study contributes to the adherence literature by
focusing on COPD, an incurable chronic disease that can be managed by effective treatment.
It also improves upon previous works by employing objective indicators such as the count of
healthy days as a measure of health stock and smoking cessation and flu vaccine status as
indicators of adherence.
Empirical model
Inspired by the Grossman model of health production, the stock of health is
represented by the count of healthy days reported in a typical month by an individual with
COPD:
Count of healthy days = 30 – count of sick days

(4.1)

The count of healthy days is defined as the number of days in a typical month during
which a typical patient is able to engage in their usual daily activities including self-care,
work, and recreation, unimpeded by ill health. It will be modeled as a function of adherence
with controls for biological and socioeconomic heterogeneity in the estimation equations.
A significant number of zeros are expected in a count model. Therefore, the choice of
econometric method is crucial to the study outcome. Count data usually follow a Poisson
distribution; however, this often fails to hold in practice due to overdispersion (i.e., data
variance greater than the mean) or the excess zero problem. Zeros in the data may arise from
multiple sources in a count model. Either adherence may not have an effect on the health
stock; or the probability of an effect though greater than zero yields zero days of good health
from the stock. These possibilities caution against implementing a simple Poisson regression
model. Overdispersion also limits implementing a zero inflated Poisson model. A less
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restrictive negative binomial regression model may be employed in the presence of
overdispersion and excess zeros (Cameron and Trivedi, 2010).
By further assuming that different sets of factors4 determine if adherence has an effect
on the health stock, and the quantity of healthy days, a latent dependent model and zero
truncated negative binomial (ZTNB) model can be implemented within a double hurdle (DH)
framework (Cragg, 1971). The DH model is similar to the Heckman model in the assumption
of positive and zero values generated by separate processes but differs in that the DH allows
zero observations in the second hurdle. The DH model is also preferred to OLS regression
which produces biased estimates in the presence of skewed data (Cameron and Trivedi,
2010).
The DH specification comprises two parts, a participation model (or hurdle) and an
intensity model. The participation hurdle estimates the probability of treatment adherence
having an effect on the health stock in COPD while the intensity hurdle estimates the flow of
healthy days conditional upon non-zero probability in the first hurdle. The DH model thus
enables a separate analysis of the determinants of participation and intensity decisions
(Aristei, Perali and Pieroni, 2008). The participation equation employs a probit regression
while the flow of healthy days is estimated using ZTNB regression estimation in the second
hurdle. Demographic factors are usually included in the participation model (Aristei et al.,
2008). Following Ogundari and Abdulai (2014), the participation equation is represented by
Equation 4.2.
𝑑𝑖∗ = 𝛼𝑿𝒊𝒋 + 𝜀𝑖 ,

4

𝑑𝑖 = {

1 𝑖𝑓
0 𝑖𝑓

There could be overlaps.
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𝑑𝑖∗ > 0
𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒

(4.2)

Where di* is the latent variable representing whether a COPD patient experiences days of
good health, di are observed variables associated with di*, X is a vector of biological or
demographic variables (j = gender, age and race) hypothesized to explain the first hurdle, α is
a vector of parameter estimates and ε are the random errors of the regression. In the intensity
equation (Equation 4.3), the participation equation is augmented with socioeconomic
variables including education, employment status, possession of health insurance; and an
indicator variable for alcohol consumption
𝑤𝑖∗ = 𝛿𝑴𝒊𝒋 + 𝜏𝑖 ,

𝑤𝑖 = {

𝑤𝑖∗
0

𝑖𝑓
𝑖𝑓

𝑑𝑖∗ > 0 𝑎𝑛𝑑 𝑤𝑖∗ > 0
𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒

(4.3)

Where wi* is a latent variable representing the count of days of good health, wi’s are variables
associated with w*, M is a vector of variables j hypothesized to explain the second hurdle, δ
is a vector of the parameter estimates and τ is the random error of the regression. Cohort and
state fixed effects are included in both stages to capture cohort variation (Wooldridge, 2015).
Data and Variables
Data
The study utilizes pooled cross-sections of the individual level data of U.S. adults
aged 18 years and above with diagnosis of COPD prior to BRFSS survey rounds in 20112013. The BRFSS database contains information on demographic, socioeconomic, personal
health, individual level behavioral risk factors associated with the leading causes of morbidity
and premature mortality, and preventive health service use among adults in the 50 U.S. States
and its territories.
Accordingly, the analysis is confined to the population of respondents who answered
‘yes’ to the question “ever told you have chronic obstructive pulmonary disease, emphysema
or chronic bronchitis?” A total of 117,942 observations comprising 39,260, 37,744 and
40,938 observations from the three surveys are included in the study sample. Owing to the
cross-sectional nature of the data and lack of information on date of diagnosis of COPD, it is
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not possible to determine temporality between smoking status and diagnosis of COPD.
However, I assume smoking status is related to diagnosis of COPD, emphysema or chronic
bronchitis as it is the most important risk factor.
Dependent and Independent variables
Count of Healthy Days
The dependent variable is the count of days of good health estimated as in equation 1
above. The survey asks “during the past thirty days, for how many days did poor physical or
mental health keep you from doing your usual activities including self-care, work and
recreation?” The number of healthy days is widely used in the health economics literature5
and correlates well with health status (Gonzalez-Lopez et al., 2015).
Adherence
Adherence to treatment plan is the key independent variable of interest and is
constructed from smoking and influenza vaccination status of respondents. The BRFSS
dataset includes an indicator for adults who are current smokers and asks “during the past 12
months have you had either a flu vaccine or a flu vaccine that was sprayed in your nose?”
The constructed measure is stratified into four levels. These are, in increasing order of
compliance: level one, current smoker + no flu vaccine; level two, current smoker + flu
vaccine; level three, quit-smoking + no flu vaccine; and level four (full adherence), quitsmoking + flu vaccine. A dummy variable is included for each level of compliance with
“current smoker + no flu vaccine” as the base. Sullivan et al. (1990) show that non-adherence
leads to greater healthcare costs while Rizzo et al. (1998) show that adherence to medication

5

Quality adjusted life years (QALY), a measure incorporating years lived in good health is a widely used as
outcome measure in studies of cost-effectiveness of healthcare interventions and technologies (Ryen and
Svensson, 2015; and Round, 2012). Disability adjusted life years (DALY), the sum of years of life lost (YLL)
and years lost due to disability (YLD) is used in estimating the burden of disease (Murray et al., 2013).
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has a positive effect on labor productivity. I hypothesize that a higher level of adherence is
associated with a higher level of a COPD patient’s health capital stock.
Control Variables
Gender: Gender heterogeneity has been observed in health status and healthcare
utilization. Courtenay (2000) studies the influence of masculinity on men’s well-being and
argues that observed gender difference may be due to differences in health beliefs and
behaviors between men and women. In particular, men are less likely than women to adopt
healthy behaviors, and also tend to engage in risky behaviors. Consistent with this, the female
gender is expected to have a greater probability of an effect on health outcome relative to
males.
Age: Age also determines health status. Working age adults usually report better
health than adults above 65 years. Moreover, increasing age after 65 years tends to be
associated with multiple co-morbidities which depreciate the health stock. The study data
include age 18–99 years. This is split into two groups, 18-44 years (young adults) and 45-99
years (adults), with 18-44 years as the base.6
Race: Racial variation in reported health status and is documented with non-Hispanic
white reporting less adverse health conditions including chronic illness than AfricanAmericans, Hispanics and other racial groups (NDHR, 2013). Plausible mechanisms include
better access to healthcare services, insurance, higher income and more efficient
transformation of information and knowledge to health (Cutler and Lleras-Muney, 2010).
Indicator variables for racial groups are included in the model with white racial group as
base.

6

The age variable in the data set is provided in three categories 18-44years, 45-64 years and 65-99years but due
to collinearity between the two older groups, both were collapsed into a single group.
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Co-morbidity: The presence of co-morbid illness represents multifactorial insults on
the health stock. A co-morbid condition could also reduce the efficiency of health investment,
thus requiring greater than usual investment to bring about a given amount of increase in
health capital relative to absence of co-morbid illness. The study data includes information on
the presence of co-morbid physical and mental illnesses. An indicator variable for co-morbid
illness is included as control and helps to isolate the effect of COPD.
Alcohol consumption: Alcohol consumption is a lifestyle factor which may affect
health. Beneficial and harmful effects of alcohol consumption are reported in the medical
literature (see e.g., Belleville, 2002; Conover and Scrimgeour, 2013; and Mentzakis et al.,
2015). Excessive use of alcohol may however lead to health stock depletion. A dummy
variable representing alcohol consumption may also indicate risky behavior (Leigh, 1999) or
serve as proxy for social influence on health.
Education: Education correlates positively with health status. Cutler and LlerasMuney (2010) find evidence that 30 percent of the education gradient in health can be
explained by income, health insurance and family background and 30 percent by more
efficient transformation of information into health. Cutler et al. (2010) suggest that behavioral
risk factors do not play a primary role in the education gradient and conclude that the health
returns to education continues to grow. Dummies for high school graduation; some college
education; and college graduation are included in the intensity model with some high school
education as the base. I expect the coefficients on the dummies to increase with educational
attainment.
Marital status: Membership of a married or unmarried couple are combined into one
group of a dummy variable while the combination of never married, divorced, widowed or
separated into the other group constitutes the base. Wilson and Oswald (2005) suggest that
marriage may have a positive effect on health. The effect of marriage on health status may be
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due to a spouse augmenting health production in the home or altering preferences for risky
behavior (Santerre and Neun, 2013).
Employment status: Possession of health insurance in the U.S. and hence access to
healthcare services which may be used in the production of health is traditionally tied to
employment. Employment also ensures access to income which also facilitates health
investments. Schaller and Stevens (2015) find an increase in self-report of worsening health
following job loss; and reduction in utilization among those for whom health insurance was
tied to the lost job. Eibich (2015), however, finds that retirement improves physical and
mental health due to absence of stress and strain of work and increased substitution of health
promoting activities.
Health insurance: An indicator of respondents’ health insurance status is included in
the model as possession facilitates access to healthcare, an input in health production. Health
insurance facilitates access to healthcare services by lowering the financial barrier to
healthcare services. Xu and Jensen (2012) however find no difference in illness-related
absenteeism between older insured and uninsured workers in the U.S.
Results
The descriptive summary of the study sample presented in Table 8 shows that the
mean number of days in good health in a typical month for the entire sample is 19.45 days
during the 3-year study period. Thirty-four percent (34 percent) of the sample were current
smokers while 56 percent had taken the flu vaccine. The mean number of healthy days was
18.9 days among current smokers who had not taken the flu vaccine; 17.7 days among
current smokers who had taken the flu vaccine; 20.18 days among those who were not
smokers and had not taken the flu shot; and 20.27 days among fully compliant patients. The
study population was about evenly distributed among the levels of adherence.
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Table 8. Summary statistics of COPD patient sample. Mean (standard error)
Variable

Total
sample

Days in good health
19.45 (12.07)
Female
0.66 (0.48)
Male
0.35 (0.48)
Age 18-44yrs
0.1 (0.31)
Age 45-99yrs
0.9 (0.31)
White
0.81 (0.39)
Black
0.08 (0.27)
Hispanic
0.05 (0.21)
Other race
0.04 (0.18)
Multiracial
0.03 (0.17)
Flu vaccine
0.56 (0.5)
Current smoker
0.34 (0.47)
Comorbidity
0.84 (0.37)
Marital union
0.41 (0.49)
Alcohol consumption
0.35 (0.48)
Less than high school
0.17 (0.37)
High school graduation 0.37 (0.48)
Some college education 0.29 (0.45)
College graduation
0.18 (0.38)
Employed
0.23 (0.42)
Health insurance
0.82 (0.39)
2011
0.33 (0.47)
2012
0.32 (0.47)
2013
0.35 (0.48)
a
N= 87,474

Current
Current
smoker + smoker + flu
no flu
vaccine
vaccine
18.5 (12.2) 17.7 (12.3)
0.64 (0.48) 0.66 (0.47)
0.36 (0.48) 0.34 (0.47)
0.21 (0.41) 0.09 (0.29)
0.79 (0.41) 0.91 (0.29)
0.8 (0.4)
0.83 (0.37)
0.08 (0.27) 0.07 (0.25)
0.04 (0.19) 0.03 (0.17)
0.04 (0.2)
0.04 (0.2)
0.04 (0.19) 0.03 (0.18)

0.81 (0.39)
0.37 (0.48)
0.41 (0.49)
0.22 (0.41)
0.39 (0.49)
0.29 (0.45)
0.1 (0.31)
0.31 (0.46)
0.71 (0.45)
0.34 (0.47)
0.33 (0.47)
0.34 (0.47)

0.87 (0.33)
0.35 (0.48)
0.35 (0.48)
0.19 (0.39)
0.39 (0.49)
0.29 (0.45)
0.13 (0.33)
0.21 (0.41)
0.88 (0.32)
0.34 (0.47)
0.33 (0.47)
0.33 (0.47)

Quit
smoking +
no flu
vaccine
20.18 (11.8)
0.66 (0.47)
0.34 (0.47)
0.13 (0.33)
0.87 (0.33)
0.76 (0.43)
0.1 (0.31)
0.07 (0.25)
0.04 (0.18)
0.03 (0.17)

0.81 (0.39)
0.43 (0.5)
0.34 (0.48)
0.15 (0.36)
0.35 (0.48)
0.3 (0.46)
0.2 (0.4)
0.27 (0.45)
0.8 (0.4)
0.33 (0.47)
0.33 (0.47)
0.34 (0.48)

Quit smoking
+ flu vaccine

20.27 (11.89)
0.65 (0.48)
0.35 (0.48)
0.04 (0.2)
0.96 (0.2)
0.85 (0.36)
0.07 (0.25)
0.04 (0.19)
0.03 (0.17)
0.02 (0.15)

0.86 (0.34)
0.44 (0.5)
0.33 (0.47)
0.14 (0.35)
0.35 (0.48)
0.28 (0.45)
0.23 (0.42)
0.18 (0.38)
0.91 (0.29)
0.33 (0.47)
0.33 (0.47)
0.34 (0.47)

Table 9 groups the study sample according to days of good health into zero days and nonzero days of good health. A comparison of observations reporting zero days of good health
(signifying consistent poor health) with those reporting non-zero days shows that the two
groups are statistically different. The estimation results are presented in Table 10. The first
hurdle comprises probit estimates of the effects of adherence and biological factors on
healthy days while the second hurdle estimates the number of healthy days using the zero
truncated negative binomial (ZTNB) method and controlling for biological and
environmental factors. The base group for adherence comprised current smokers who had not
received the flu vaccine (the least adherent group).

63

Table 9: A comparison of observation that reported zero and at least a healthy day
Variable

Total sample

With zero days
of good health

Mean diff

19.45 (12.07)

With non-zero
days of good
health
24.61 (7.57)

Days in good health

0

-24.61***

Current smoker + no flu vaccine
Current smoker + flu vaccine
Quit smoking + no flu vaccine
Quit smoking + flu vaccine

0.17 (0.38)
0.14 (0.35)
0.24 (0.43)
0.38 (0.49)

0.17 (0.37)
0.14 (0.34)
0.25 (0.43)
0.39 (0.49)

0.2 (0.4)
0.18 (0.39)
0.25 (0.43)
0.34 (0.47)

0.02***
0.04***
-0.03***
-0.03***

Female
Male

0.66 (0.48)
0.35 (0.48)

0.66 (0.48)
0.34 (0.48)

0.64 (0.48)
0.36 (0.48)

-0.02***
0.02***

0.1 (0.31)
0.9 (0.31)

0.11 (0.31)
0.89 (0.31)

0.08 (0.27)
0.92 (0.27)

-0.04***
0.04***

White
Black
Hispanic
Other race
Multiracial

0.81 (0.39)
0.08 (0.27)
0.05 (0.21)
0.04 (0.18)
0.03 (0.17)

0.82 (0.39)
0.08 (0.27)
0.05 (0.21)
0.03 (0.18)
0.03 (0.16)

0.8 (0.4)
0.08 (0.27)
0.05 (0.21)
0.04 (0.2)
0.04 (0.19)

-0.006*
-0.009***
-0.002
0.006***
0.01***

Flu vaccine

0.56 (0.5)

0.56 (0.5)

0.55 (0.5)

0.007*

Current smoker

0.34 (0.47)

0.33 (0.47)

0.41 (0.49)

0.06***

Employed

0.23 (0.42)

0.26 (0.44)

0.06 (0.24)

-0.19***

Comorbidity

0.84 (0.37)

0.82 (0.38)

0.82 (0.38)

0.08***

Marital union

0.41 (0.49)

0.42 (0.49)

0.94 (0.23)

-0.04***

Alcohol consumption

0.35 (0.48)

0.38 (0.48)

0.23 (0.42)

-0.13***

Less than high school
High school graduation
Some college education
College graduate
Health insurance
N

0.17 (0.37)
0.37 (0.48)
0.29 (0.45)
0.18 (0.38)
0.82 (0.39)
87,474

0.16 (0.36)
0.37 (0.48)
0.29 (0.45)
0.19 (0.39)
0.81 (0.39)
69,157

0.23 (0.42)
0.37 (0.48)
0.27 (0.45)
0.13 (0.34)
0.84 (0.37)
18,317

0.07***
0.0008
-0.02***
-0.05***
0.03***

Age 18-44yrs
Age 45-99yrs

*

p<0.10, **p<0.05, ***p<0.01

The key adherence variables are statistically significant while the control variables are
generally also statistically significant.
The marginal effects (also reported in Table 10) show that relative to the base group
(total non-adherence), full adherence increases the likelihood of healthy days by 4 percent.
64

The adherence status “quitting smoking + no vaccination” is associated with 3 percent greater
likelihood of reporting good health while the “current smoker + flu vaccination” adherence
status is associated with a negligible 0.8 percent lower likelihood of an effect on healthy
days.
Being female relative to male is associated with 4.0 percent higher probability of good
health. Ages 45-99 years is associated with 7.0 percent less probability relative to 18-44
years. Blacks are associated with 2.0 percent greater probability of an effect relative to whites
while Hispanics, other races and multiracial ethnic groups are associated with 2.0 percent, 3.0
percent and 6.0 percent less likelihood respectively than whites to experience an effect on
health days. A co-morbid illness is associated with 12.0 percent reduction in likelihood of an
effect compared with absence of physical or mental co-morbid illness.
Conditional upon adherence eliciting an effect in the first hurdle, marginal effects of
second hurdle factors show that in a typical month, smoking currently but being vaccinated is
associated with 0.50 day less of good health relative to total non-adherence. Quitting smoking
alone adds 0.50 day of good health relative to total non-adherence while full compliance is
associated with 0.67 more healthy days. Being a female reduces the number of healthy days
by 0.40 days compared with males; ages 45-99 years is associated with additional 0.17 day of
good health than age18-44 years.
Black ethnicity is associated with additional 0.13 healthy days compared with white while
being Hispanic, other or multiracial respectively reduce healthy days by 0.16, 0.69 and 1.26
days relative to white.
Co-morbid illness is associated with 2.57 days less than without. Alcohol
consumption is associated 0.57 day addition to the health stock relative to no consumption.
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Table 10. Double hurdle regression and marginal effects estimates
Variables

1st hurdle
Probit
Marginal effect

ZTNB

2nd hurdle
Marginal effect

Adherence (base: current
smoker + no flu vaccine)
Current smoker + flu vaccine
Quit smoking + no flu vaccine
Quit smoking + flu vaccine

-0.03 (0.02)*
0.13 (0.01)***
0.15 (0.01)***

-0.008 (0.005)*
0.03 (0.004)***
0.04 (0.004)***

-0.02 (0.006)***
0.02 (0.005)***
0.03 (0.005)***

-0.46 (0.13)***
0.49 (0.11)***
0.67 (0.12)***

Female (base: Male)

0.14 (0.01)***

0.04 (0.003)***

-0.02 (0.004)***

-0.41 (0.09)***

-0.25 (.02)***

-0.07 (.004)***

0.0007 (0.004)*

0.17 (0.1)*

0.06 (0.02)***
-0.08 (.03)***
-0.11 (.03)***
-0.18 (.03)***

0.02 (0.005)***
-0.02 (.008)***
-0.03 (.008)***
-0.06 (.009)***

0.006 (0.006)
-0.006 (0.008)
-0.03 (0.01)***
-0.06 (0.01)***

0.13 (0.15)
-0.16 (0.19)
-0.69 (0.22)***
-1.26 (0.25)***

-0.52 (.02)***

-0.12 (.003)***

-0.11 (.004)***

-2.57 (0.09)***

0.02 (0.004)***

0.57 (0.09)***

0.01 (0.006)**
0.002 (0.006)
0.02 (0.007)***
0.03 (0.004)***
0.19 (0.004)***
-0.01 (0.005)***
-0.003 (0.004)
0.003 (0.004)
3.17 (0.01)***
32,831
5907.68
0.015

0.3 (0.14)**
0.06 (0.14)
0.56 (0.16)***
0.74 (0.08)***
4.52 (0.08)***
-0.34 (0.11)***
-0.08 (0.1)
0.06 (0.1)
-0.46 (0.13)***
0.49 (0.11)***
0.67 (0.12)***
-0.41 (0.09)***

Age 45-99yrs (base: 1844years)
Race (base: white)
Black
Hispanic
Other race
Multiracial
Comorbidity (base: no
comorbidity)
Alcohol consumption (base:
no alcohol)
Completed high school
Some college education
College graduate
Marital union (base: single)
Employed (base: unemployed)
Insured (base: uninsured)
Year 2012
Year 2013
Constant
N
Wald χ2
R-squared

-0.02 (0.01)*
-0.01 (0.01)
1.25 (0.04)***
85,922
2026.56
0.024

-0.008 (0.003)**
-0.002 (0.003)
-0.008 (0.005)*
0.03 (0.004)***
0.04 (0.004)***
0.04 (0.003)***

a

Marginal effects for factor levels is the discrete change from the base level
p<0.10*, p<0.05**, p<0.01***
c
Standard errors in parentheses
b

High school completion is associated with additional 0.3 day of good health compared with
those who have less than high school education while some college education and college
completion are is associated with addition of 0.06 and 0.56 days of good health respectively.
Being married (and membership of an unmarried union) relative single is associated with
additional 0.74 days of good health. Being in employment is associated with 4.52 days more
66

of good health than the unemployed while health insurance is associated with 0.34 day less of
good health compared with not having health insurance. Relative to 2011, year 2012 and
2013 are associated with a lower probability of an effect.
Discussion
The overall results are consistent with the theoretical expectation of positively signed
coefficients of adherence in the participation stage and, conditional upon a positive
probability, a positive number of healthy days relative to the base group of total nonadherence. As expected, non-smoking status increases the probability of experiencing good
health regardless of flu vaccination status. Estimated coefficients suggest that full adherence
has a higher probability of affecting health status than quitting smoking only. Conditional on
this, full adherence also adds more days of good health than the alternative of quitting
smoking alone. Both results are statistically significant at 1 percent level and suggest that
smoking cessation and flu vaccination are complementary inputs in health production in
COPD.
The results are also consistent with the evidence of smoking cessation’s effectiveness
as a health investment as it removes the source of depreciation of the health capital. The
reduced effect of flu vaccination alone could be due to the fact that it is usually taken around
the flu season whereas chest infection could also occur outside the season. Moreover, flu
vaccine effectiveness also depends on accurate forecast of the flu virus strain and
development of an appropriate vaccine. Unexpectedly, however, flu vaccination alone is
associated with statistically significant reduction in the probability of an effect on health
stock and number of days of good health.
Although being female is associated with a relatively higher probability of an effect,
conditional upon an effect, being female is associated with a reduction in the number of days
of good health. Opposite signs for the coefficients in the participation and intensity stages is
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consistent with the behavioral model (Yen and Jones, 2002 in Okunade et al., 2010). Age
also has opposite signs in both stages. This observation ought to be taken with caution as the
categorization lumps together active individuals with those past the retirement age, and with
whom are associated increasing incidence of co-morbidity. It is plausible that retirees with
COPD have a lower opportunity cost of time and increasingly substitute health promoting
activities (Eibich, 2015).
Black ethnicity relative to white is associated with increased probability of reporting
good health but there is no difference in healthy days generated. The observed increase in
probability may reflect the narrowing gap between blacks and whites in access to quality and
effective healthcare services, and health insurance especially since the passage of the
Affordable Care Act (NHDR, 2014). Hispanics and other racial groups are however
associated with lower probabilities of good health and reduction in the days of good health.
Although the probabilities are significant, there is no significant difference between
Hispanics and non-Hispanic whites in the number of healthy days. A significant decrease in
the number of days of good health is observed among other racial and multiracial origin
population groups. These results may reflect pervasive service access disparity relative to
whites.
Co-morbid illness is significantly associated with both a lower probability and
additional days of good health. A co-morbid illness may act by countering investment in
health by adhering to COPD treatment and depending on the severity, use up existing capital
stock of health. Alcohol consumption is significantly associated with 0.57 more days of good
health. Although I do not have information on the quantity of alcohol consumed, the result is
surprising as alcohol consumption is considered a risky and unhealthy behavior which may
deplete the health stock. Alcohol consumption may be health producing however if it protects
the heart in moderate consumption.
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I find monotonically increasing returns to education of 0.3, 0.6 and 0.56 additional
days of good health respectively for high school completion, some college education and
college graduation relative to those who did not graduate from high school. The difference is
not significant for those who have some college education. Relative to singles, being a
member of a married or unmarried couple is associated with more health days. Employment
is significantly associated with 4.5 more days of good health relative to unemployment.
Employment facilitates access to health insurance and income, important factors which
facilitate health production. It is also possible that COPD patients who are able to remain
employed feel compelled to go to work and so are able to report a lower rate of absenteeism
even though they are unproductive at work (DiBonaventura, Paulose-Ram, Su et al., 2012a
and 2012b). Relative to those who do not have health insurance, having health insurance is
significantly associated with reduction in the number of healthy days. Insurance lowers health
access barriers and therefore is expected to facilitate the production of healthy days. Health
insurance may however lead to moral hazard if after purchasing insurance the insured
engages in unhealthy behaviors which depreciate the health capital stock.
Relative to 2011, years 2012 and 2013 are associated with lower probabilities of
healthy days but this is only significant in 2012. This change may be observed if insured
patients change their behavior after obtaining health insurance under the 2010 Affordable
Care Act.
Conclusion
COPD is a progressive disease of the lungs associated with significant morbidity and
mortality especially among adults (Strassels et al., 2001). It causes significant impairment at
work (DiBonaventura et al., 2012a and 2012b), and puts pressure on health care resource use.
Smoking cessation and regular annual flu vaccination are efficacious treatment strategies but
their effectiveness depends on adherence to treat.
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I posit that adherence is an investment in the stock of health capital and study the
effect of the decision to adhere to treatment on the health stock in COPD. The decision to
invest in health by adhering to treatment is modelled as a two-stage process using a double
hurdle (DH) framework. Fitting the model to BRFSS 2011-2013 data, adhering to smoking
cessation advice alone increases the probability of an effect by 3 percent and adds 0.49 days
(in a typical month) to the health stock while full adherence is associated with 4 percent
increase in probability of an effect and additional 0.67 healthy days. Influenza vaccination
alone is associated with decreases in the probability of an effect and number of healthy days
relative to unvaccinated smokers. The findings suggest that smoking cessation and influenza
vaccination are complements in COPD treatment.
In modelling the number of healthy days, this study has employed a sample of COPD
patients in whom illness severity is unobserved. If those experiencing non-zero days of poor
health differ in illness severity from those with zero days of poor health then the estimates
may be biased. Future studies should incorporate heterogeneity in illness severity and
estimate the economic value of additions to the health stock. The findings suggest that payers
include the monitoring of patient education which emphasizes the importance of treatment
adherence as a measure of care quality.
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APPENDIX A
Previous studies reporting income elasticities of prescription drug utilization and expenditures
Study
Data
Method
Dependent variable
1

2

Leth‐Petersen, S.,
and Skipper, N.
(2014)
Garavaglia, S.,
Goldfarb, S., and
Frazee, S. G.
(2013)

3

Creel, M., and
Farell, M. (2011)

4

Clemente, J.,
Marcuello, C., and
Montanes, A.
(2008)

1995-2003 panel data of
near-retirement individuals
in Denmark
2010-2012 pooled, US
individual level crosssectional data of large
commercial pharmacy
benefits claims database
1996-2000 U.S. Medical
Expenditures Panel Survey

Mixed models; panel
data and instrumental
variable methods
Comparison of mean
utilization by income
decile

Share of income spent on
prescription drugs

Negative binomial
regression

Number of prescription
drugs taken

1960-2003 OECD data for
20 countries separately
broken into pharmaceutical
(private and government)
and non-pharmaceutical
components of health-care
expenditure

Panel time-series (unit
root and cointegration)
analysis

Pharmaceutical health-care
expenditure
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Annual average days supply
of prescription medications

Findings on income elasticity
estimates
-0.62 budget share elasticity;
0.38 utilization elasticity (from the
preferred model)
Utilization increases (falls) with
income for persons below (above) age
35 years

-0.0012 income coefficient, which
implies for year 2000 an income
elasticity estimate at data means of 0.0075
Private pharmaceutical expenditure
model: 0.30 (Germany) to 1.52
(Australia) range, including 1.03 (tvalue=0.08) for the U.S., in countries
with insurance finance system; -0.41
(Portugal) to (0.60 (Iceland and
Finland) in countries with tax finance
system
Government pharmaceutical
expenditure model: -0.99 (Canada) to
0.98 (Australia) range, including 0.88
(t-value=0.13) for the U.S., in
countries with insured finance
system; -1.87 (Spain) to 3.31 (Italy)
in countries with tax finance system

Previous studies reporting income elasticities of prescription drug utilization and expenditures
Study
Data
Method
Dependent variable
5

Huttin, C. (2000)1

Subset of 1987 US NMES
(National Medical
Expenditure Survey) for
individuals with private
health insurance

Multiple regression
model using clustered
data

Prescription expenditure

6

Huttin, C. (1997)2

Subsamples of 1987 US
National Medical
Expenditure Survey for the
privately insured

Multiple regression

Pharmaceutical expenditure

7

Suraratdecha, C.
(1996)

1980-1990 pooled timeseries, cross-sectional data
of US states

Prescription drug
expenditure

8

Coulson, N. E., and
Stuart, B. C. (1995)

Panel constructed from a
1990 survey of health
insurance and medicines

MLE and GLS
estimates of Extended
Box-Cox regression
model
Ordinary Least Squares
(OLS)

Prescriptions filled in the 2
weeks before survey;
number of persons with any

Findings on income elasticity
estimates
Regional variations: 0.036 in East
South Central and 0.021 in West
South Central regions (Table 3);
Socioeconomic clusters of patients
within regions (Table 4): -0.032
(region2 cluster22), 0.042 (region4
cluster42), -0.045 (region4 cluster43),
0.068 (region6 cluster61), 0.039
(region6 cluster62), 0.04 (region7
cluster71), 0.047 (region7 cluster72
and cluster75)
-0.09 (-0.04) coefficient on family
income for group plan (non-group
plan) holders;
-0.08 (-0.04) coefficient on personal
income for group plan (non-group
plan) holders.
0.113 income elasticity of
prescription drug expenditure

0.08 (-0.04) coefficient on income
$12,000-15,000 ($15,000-18,000) for
number of prescriptions filled by
Medicare enrollees in the 2 weeks

1

Table 2 in Huttin (2000) reports -0.071 income elasticity estimate (insignificant) at the national level. Here, we summarize only the statistically significant elasticity
estimates at the regional and clusters within regions.
2

Huttin (1997) also reports statistically significant negative and positive coefficients for (personal and family) income effects on: (a) outpatient use of prescribed medicines;
(b) patients with poor health; and (c) different job profiles. The results suggest that the sign of the relationship between pharmaceutical use and income differ across health
status, job stability and health plans.
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Previous studies reporting income elasticities of prescription drug utilization and expenditures
Study
Data
Method
Dependent variable
use among Pennsylvania
Medicare enrollees

9

10

Alexander, D. L.,
Flynn, J. E., and
Linkins, L. A.
(1994)
Cameron, A. C.,
Trivedi, P. K.,
Milne, F., and
Piggott, J. (1988)

number of prescriptions; per
user number of prescriptions

1980-87 pooled OECD data

2-Stage Least Squares
(2SLS)

Quantity of prescriptions
filled per capita

Household data (1977-78
Australian Health Survey)

Negative binomial
estimation

Counts of prescribed and
non-prescribed medicines

Instrumental variable
estimation

11

Eng, J. H. (1985)

1980 NMCUES data
(National Medical Care
Utilization and Expenditure
Survey).

Ordinary Least Squares
(OLS)
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Pharmaceutical expenditure
and volume of prescriptions

Findings on income elasticity
estimates
before the survey. 0.04 (-0.004)
coefficient on income $12,000-15,000
($15,000-18,000) for per user
prescriptions filled.
Positive income elasticity of
utilization (not expenditure) at
national level: 1.03 (UK), 1.79 (US
and Japan), 1.31 (France)
Income class is positively associated
with total prescriptions (0.045
coefficient) and non-prescribed
medicines (0.055 coefficient) but
negatively associated with prescribed
medicines (-0.0013 coefficient).
Instrumenting for health insurance
coverage, income is positively
associated with total prescriptions
(0.68 coefficient, t-ratio=1.18) and
non-prescribed drugs(1.09 coefficient,
t-ratio=1.93); and negative
association with prescriptions (-0.42
coefficient, t-ratio=1.62).
Negative relationship between family
income and prescription expenditure
in models estimated without nonlinear term. -0.0002 income elasticity
of pharmaceutical expenditure. With
inclusion of quadratic, income
became positive while quadratic is
negative. With volume of use models,
income has a negative effect with
prescription drug utilization (both

Previous studies reporting income elasticities of prescription drug utilization and expenditures
Study
Data
Method
Dependent variable
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Findings on income elasticity
estimates
with and without quadratic term
which is also negative. 0.013 income
elasticity of effective utilization

